<SEC-DOCUMENT>0001193125-24-146576.txt : 20240524
<SEC-HEADER>0001193125-24-146576.hdr.sgml : 20240524
<ACCEPTANCE-DATETIME>20240524090054
ACCESSION NUMBER:		0001193125-24-146576
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240523
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240524
DATE AS OF CHANGE:		20240524

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acadia Healthcare Company, Inc.
		CENTRAL INDEX KEY:			0001520697
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35331
		FILM NUMBER:		24981141

	BUSINESS ADDRESS:	
		STREET 1:		6100 TOWER CIRCLE
		STREET 2:		SUITE 1000
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
		BUSINESS PHONE:		615-861-6000

	MAIL ADDRESS:	
		STREET 1:		6100 TOWER CIRCLE
		STREET 2:		SUITE 1000
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d833064d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:achc="http://www.acadiahealthcare.com/20240523" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-500">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-05-23_to_2024-05-23">0001520697</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2024-05-23_to_2024-05-23" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2024-05-23_to_2024-05-23">--12-31</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="achc-20240523.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-05-23_to_2024-05-23"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-23</xbrli:startDate> <xbrli:endDate>2024-05-23</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, DC 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-512">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt:datemonthdayyearen" id="ixv-513">May&#160;23, 2024</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-514">Acadia Healthcare Company, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:stateprovnameen" id="ixv-515">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-516">001-35331</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-517">45-2492228</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-518">6100 Tower Circle</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-519">Suite 1000</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-520">Franklin</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:stateprovnameen" id="ixv-521">Tennessee</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-522">37067</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-523">(615)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-524">861-6000</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, including Area Code)</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-525">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-526">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-527">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-528">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-529">Common Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-530">ACHC</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:exchnameen" id="ixv-531">NASDAQ Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-532">&#9744;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Dr.&#160;Nasser Khan as Chief Operating Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;23, 2024, Acadia Healthcare Company, Inc. (the &#8220;Company&#8221;) announced the appointment of Dr.&#160;Nasser Khan as the Chief Operating Officer of the Company, effective June&#160;30, 2024. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&#160;Khan, age&#160;45, joined the Company as Operations Group President for the Company&#8217;s comprehensive treatment center business line in September 2022. Prior to joining the Company, Dr.&#160;Khan served as the Senior Vice President, Operations at Shields Health Solutions, a national provider of specialty pharmacy services to health systems and a subsidiary of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), from July 2020 to August 2022. Prior to that, Dr.&#160;Khan served as Head of Program&#160;&amp; Chief Medical Officer at Biograph Inc., a healthcare technology company, from May 2017 to June 2020. He also held a series of progressive operational leadership roles at DaVita, Inc. as Division Vice President of Hospital Services, Regional Operations Director, and Director of Strategy&#160;&amp; Special Projects. Early in his career, Dr.&#160;Khan spent time as an Engagement Manager at McKinsey&#160;&amp; Company, a leading global consulting firm. Dr.&#160;Khan holds a Doctor of Medicine (M.D.), a Master of Medical Science (M.M.S.) and a Bachelor of Arts in Human Biology from Brown University. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no arrangements or understandings between Dr.&#160;Khan and any other person pursuant to which Dr.&#160;Khan was appointed as Chief Operating Officer. There are no family relationships among any of the Company&#8217;s directors or executive officers and Dr.&#160;Khan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Employment Agreement with Dr.&#160;Khan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with his appointment, the Company and Dr.&#160;Khan have entered into an employment agreement (the &#8220;Employment Agreement&#8221;), pursuant to which Dr.&#160;Khan will be entitled to the following compensation: (i)&#160;an annualized base salary of $515,000 per year, subject to increase by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) or the Compensation Committee (the &#8220;Compensation Committee&#8221;) of the Board (&#8220;Base Salary&#8221;); (ii) eligibility to earn a target annual cash bonus of 85% of Base Salary in accordance with the Company&#8217;s annual bonus plan applicable to senior executives if and only if the performance criteria specified by the Board or the Compensation Committee for such year have been achieved, as determined by the Board or the Compensation Committee in its sole discretion; (iii)&#160;annual grants of long-term incentive awards in amounts as determined by the Compensation Committee and on terms and conditions comparable to the Company&#8217;s other executive officers; and (iv)&#160;eligibility for severance benefits upon the termination of Dr.&#160;Khan&#8217;s employment without Cause (as defined in the Employment Agreement) or due to his resignation for Good Reason (as defined in the Employment Agreement) (each, a &#8220;Qualifying Termination&#8221;). The annual grants of long-term incentive awards described above will be subject to the terms and conditions of award agreements that are substantially consistent with the award agreements issued to the other executive officers of the Company. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon a Qualifying Termination, Dr.&#160;Khan will be eligible to receive (i)&#160;his unpaid Base Salary through the date of termination (the &#8220;Termination Date&#8221;); (ii)&#160;an amount equal to the actual annual cash bonus amount to which he would be entitled with respect to the calendar year in which the Termination Date occurs, determined based on achievement of the performance objectives specified in Dr.&#160;Khan&#8217;s bonus plan for such year, as determined by the Board or the Compensation Committee in its sole discretion, which amount shall be prorated based on the actual number of days elapsed in such year prior to the Termination Date; (iii)&#160;an amount equal to one times the target annual cash bonus amount to which Dr.&#160;Khan would be entitled with respect to the calendar year in which the Termination Date occurs, determined as if all of the performance objectives specified in Dr.&#160;Khan&#8217;s bonus plan for such year have been achieved at the target level, whether or not such objectives actually have been achieved as of the Termination Date; (iv)&#160;an amount equal to 12 months of his Base Salary as in effect on the Termination Date <span style="white-space:nowrap">(such&#160;12-month&#160;period,</span> the &#8220;Severance Period&#8221;); (v)&#160;payment of the annual cash bonus for the prior year, to the extent not previously paid; (vi)&#160;payment in respect of any unused paid time off and sick pay of Dr.&#160;Khan, in such amounts as have accrued as of the Termination Date, and reimbursement of any business expenses incurred by Dr.&#160;Khan but not reimbursed prior to the Termination Date; and (vii)&#160;reimbursement for the cost of any COBRA (as defined in the Employment Agreement) premiums incurred by him during the Severance Period. Upon a Qualifying Termination, all equity and equity-based awards granted to Dr.&#160;Khan prior to the Termination Date (the &#8220;Equity Awards&#8221;) shall be treated as set forth below: (A)&#160;the Equity Awards subject to time-based vesting requirements will be deemed fully vested on the Termination Date; and (B)&#160;the Equity Awards subject to performance-based vesting requirements will remain outstanding and eligible to vest based on actual achievement of the applicable performance conditions, subject to the terms and conditions set forth in the applicable award agreement and/or governing documentation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Employment Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Employment Agreement, a copy of which is attached as <span style="text-decoration:underline">Exhibit 10.1</span> and incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">John Hollinsworth Retirement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;23, 2024, the Company announced that John S. Hollinsworth will retire from his position as the Company&#8217;s Executive Vice President of Operations effective June&#160;30, 2024. In connection with his retirement from the Company, the Company entered into a separation and consulting agreement (the &#8220;Hollinsworth Separation and Consulting Agreement&#8221;) with Mr.&#160;Hollinsworth. Pursuant to the Hollinsworth Separation and Consulting Agreement, Mr.&#160;Hollinsworth will make himself available to provide transition advisory services during the period immediately following Mr.&#160;Hollinsworth&#8217;s resignation and ending on December&#160;31, 2024 in exchange for a monthly payment of $10,000. In addition, Mr.&#160;Hollinsworth will remain eligible to earn an annual cash bonus for the 2024 performance year, determined based on actual performance achievement, as determined by the Board or the Compensation Committee in its sole discretion, which amount shall be prorated based on the actual number of days elapsed during the 2024 calendar year prior to Mr.&#160;Hollinsworth&#8217;s resignation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Hollinsworth Separation and Consulting Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Hollinsworth Separation and Consulting Agreement, a copy of which is attached hereto as <span style="text-decoration:underline">Exhibit 10.2</span> and incorporated by reference herein. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.03</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As further discussed in Item 5.07 below, on May&#160;23, 2024, at the 2024 annual meeting of stockholders of the Company (the &#8220;Annual Meeting&#8221;), the stockholders approved an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation (the &#8220;Certificate of Incorporation&#8221;) to declassify the Board, as more fully described in the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on April&#160;9, 2024. The amendment became effective upon the filing of the Certificate of Amendment to the Certificate of Incorporation (the &#8220;Certificate of Amendment&#8221;) with the Secretary of State of the State of Delaware on May&#160;23, 2024. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the amendment to the Certificate of Incorporation does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Certificate of Amendment, a copy of which is included in the complete copy of the Certificate of Incorporation, as amended, attached to this Current Report on Form <span style="white-space:nowrap">8-K</span> as&#160;<span style="text-decoration:underline">Exhibit 3.1</span>&#160;and incorporated by reference herein. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.07</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company held its annual meeting of stockholders on May&#160;23, 2024. The proposals considered at the Annual Meeting were voted on as follows: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.&#8195;The individuals listed below were elected to serve as Class&#160;I directors until the Company&#8217;s annual meeting of stockholders in 2027 or until their successors have been elected and take office. The voting results were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:58%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom"/>
<td style="width:12%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom">For</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom">Against</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom">Abstain</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">E. Perot Bissell</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">70,770,458</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,566,099</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,042</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:right">2,344,663</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vicky B. Gregg</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">83,679,485</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,659,998</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,116</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2,344,663</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christopher H. Hunter</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">85,081,817</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,258,404</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24,378</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2,344,663</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.&#8195;The Company&#8217;s stockholders approved the amendment to the Company&#8217;s Certificate of Incorporation to declassify the Board, by the following vote:: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:80%;border:0;margin:0 auto">


<tr>

<td style="width:25%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:21%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:21%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:27%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center">86,345,351</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">9,432</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">9,816</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">2,344,663</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. &#8195;The Company&#8217;s stockholders approved, on a <span style="white-space:nowrap">non-binding</span> advisory basis, the compensation of the Company&#8217;s Named Executive Officers (as defined in the Company&#8217;s definitive proxy statement filed with the SEC on April&#160;9, 2024), by the following vote: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:80%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:23%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:21%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:26%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center">84,812,413</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">1,519,977</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">32,209</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">2,344,663</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.&#8195;The Company&#8217;s stockholders ratified the appointment of Ernst&#160;&amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2024, by the following vote: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:80%;border:0;margin:0 auto">


<tr>

<td style="width:36%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:30%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">Abstain</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center">88,107,702</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">576,276</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">25,284</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#160;<span style="text-decoration:underline">Exhibits</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following exhibits are filed herewith: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br/>No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d833064dex31.htm">Amended and Restated Certificate of Incorporation, as amended </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d833064dex101.htm">Employment Agreement, dated as of May&#160;23, 2024, by and between Acadia Management Company, Inc. and Dr.&#160;Nasser Khan </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d833064dex102.htm">Separation and Consulting Agreement, dated May&#160;23, 2024, between Acadia Management Company, LLC and John S. Hollinsworth </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: May&#160;24, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">ACADIA HEALTHCARE COMPANY, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian P. Farley</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Brian P. Farley</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, Secretary and General Counsel</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d833064dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND
RESTATED CERTIFICATE OF INCORPORATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACADIA HEALTHCARE COMPANY, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ACADIA HEALTHCARE COMPANY, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the
&#147;<U>Corporation</U>&#148;), does hereby certify: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FIRST</B>: The name of the Corporation is Acadia Healthcare Company, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECOND</B>: The Amended and Restated Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of
Delaware on October&nbsp;28, 2011. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIRD</B>: Amendments to the Certificate of Incorporation of the Corporation were filed with the
Secretary of State of the State of Delaware on March&nbsp;3, 2016 and May&nbsp;25, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FOURTH</B>: The Board of Directors of the
Corporation, acting in accordance with the provisions of Sections 141 and 242 of the General Corporation Law of the State of Delaware, adopted resolutions to amend Section&nbsp;3 of ARTICLE SIX of the Amended and Restated Certificate of
Incorporation, as amended, so that, as amended, it shall be and read in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;Section&nbsp;3. <U>Classes of
Directors</U>. From November&nbsp;1, 2011 (the &#147;<U>Effective Time</U>&#148;), and continuing until such time as directors are elected for a term expiring at the next succeeding annual meeting of stockholders, the directors of the Corporation,
other than those who may be elected by the holders of any series of Preferred Stock under specified circumstances, shall be divided into three classes, hereby designated Class&nbsp;I, Class&nbsp;II and Class&nbsp;III.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FIFTH</B>: The Board of Directors of the Corporation, acting in accordance with the provisions of Sections 141 and 242 of the General
Corporation Law of the State of Delaware, adopted resolutions to amend Section&nbsp;4 of ARTICLE SIX of the Amended and Restated Certificate of Incorporation, as amended, so that, as amended, it shall be restated in its entirety as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;Section&nbsp;4. <U>Majority Voting; Term of Office</U>. A nominee for director shall be elected to the Board of Directors if a majority
of the votes cast are in favor of such nominee&#146;s election; provided, however, that, if the number of nominees for director exceeds the number of directors to be elected, directors shall be elected by a plurality of the votes of the shares
present in person or represented by proxy at any meeting of stockholders held to elect directors and entitled to vote on such election of directors. At each annual meeting of stockholders, directors will be elected to replace all of those whose
terms expire at such annual meeting. At the annual meeting of stockholders held in 2025 and 2026, the successors of the class of directors whose term expires at such meeting shall be elected at such meeting to hold office for a term expiring at the
annual meeting of stockholders held in the third year following the year of their election. At the annual meeting of stockholders held in 2027, the successors of the class of directors whose term expires at such meeting shall be elected at such
meeting to hold office for a term expiring at the annual meeting of stockholders held in the second year following the year of their election. At the annual meeting of stockholders held in 2028, the successors of the class of directors whose term
expires at such meeting shall be elected at such meeting to hold office for a term expiring at the next annual meeting of stockholders. Beginning with the 2029 annual meeting of stockholders, each director shall be elected for a term expiring at the
next succeeding annual meeting of stockholders, and until his or her successor is duly elected and qualified. Each newly elected director shall remain in office until their respective successors shall have been duly elected and qualified, or until
his or her earlier death, resignation or removal. Nothing in this Certificate of Incorporation shall preclude a director from serving consecutive terms. Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall
so provide.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SIXTH</B>: The above amendment to the Amended and Restated Certificate of Incorporation of the Corporation, as
amended, was duly adopted and approved at an annual meeting of the stockholders in accordance with the provisions of Section&nbsp;242 of the General Corporation Law of the State of Delaware. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Corporation has caused certificate to be signed on this 23rd
day of May, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ACADIA HEALTHCARE COMPANY, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian P. Farley</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Brian P. Farley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Vice President, General Counsel and Secretary</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND
RESTATED CERTIFICATE OF INCORPORATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACADIA HEALTHCARE COMPANY, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ACADIA HEALTHCARE COMPANY, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the
&#147;<U>Corporation</U>&#148;), does hereby certify: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FIRST</B>: The name of the Corporation is Acadia Healthcare Company, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECOND</B>: The Amended and Restated Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of
Delaware on October&nbsp;28, 2011. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIRD</B>: An Amendment to the Certificate of Incorporation of the Corporation was filed with the
Secretary of State of the State of Delaware on March&nbsp;3, 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FOURTH</B>: The Board of Directors of the Corporation, acting in
accordance with the provisions of Sections 141 and 242 of the General Corporation Law of the State of Delaware, adopted resolutions to amend Section&nbsp;4 of ARTICLE SIX of the Amended and Restated Certificate of Incorporation, as amended, so that,
as amended, it shall be and read in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Section&nbsp;4.<U></U><U>&nbsp;Majority Voting; Term of Office</U>. A
nominee for director shall be elected to the Board of Directors if a majority of the votes cast are in favor of such nominee&#146;s election; provided; however, that, if the number of nominees for director exceeds the number of directors to be
elected, directors shall be elected by a plurality of the votes of the shares present in person or represented by proxy at any meeting of stockholders held to elect directors and entitled to vote on such election of directors. At each annual meeting
of stockholders, directors elected to replace those of a Class&nbsp;whose terms expire at such annual meeting shall be elected for a term expiring at the third succeeding annual meeting of stockholders after their election and shall remain in office
until their respective successors shall have been duly elected and qualified. Each director shall hold office until the annual meeting of stockholders for the year in which such director&#146;s term expires and a successor is duly elected and
qualified or until his or her earlier death, resignation or removal. Nothing in this Certificate of Incorporation shall preclude a director from serving consecutive terms. Elections of directors need not be by written ballot unless the Bylaws of the
Corporation shall so provide.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FIFTH</B>: The above amendment to the Amended and Restated Certificate of Incorporation of the
Corporation, as amended, was duly adopted and approved at an annual meeting of the stockholders in accordance with the provisions of Section&nbsp;242 of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Corporation has caused certificate to be signed on this 25th day of May&nbsp;, 2017. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ACADIA HEALTHCARE COMPANY, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher L. Howard</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Christopher L. Howard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Vice President, General Counsel and Secretary</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND
RESTATED CERTIFICATE OF INCORPORATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACADIA HEALTHCARE COMPANY, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ACADIA HEALTHCARE COMPANY, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the
&#147;<U>Corporation</U>&#148;), does hereby certify: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FIRST</B>: The name of the Corporation is Acadia Healthcare Company, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECOND</B>: The Amended and Restated Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of
Delaware on October&nbsp;28, 2011. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIRD</B>: The Board of Directors of the Corporation, acting in accordance with the provisions of
Sections 141 and 242 of the General Corporation Law of the State of Delaware, adopted resolutions to amend Part A of ARTICLE FOUR of the Amended and Restated Certificate of Incorporation so that, as amended, it shall be and read in its entirety as
follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#147;PART A. AUTHORIZED SHARES </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The total number of shares of all classes of capital stock which the Corporation shall have authority to issue is 190,000,000
shares, consisting of: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. 10,000,000 shares of Preferred Stock, par value $0.01 per share (the &#147;<U>Preferred
Stock</U>&#148;); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. 180,000,000 shares of Common Stock, par value $0.01 per share (the &#147;<U>Common
Stock</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Preferred Stock and the Common Stock shall have the rights, preferences and limitations set forth
below.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FOURTH</B>: The above amendment to the Amended and Restated Certificate of Incorporation of the Corporation was duly
adopted and approved at a special meeting of the stockholders in accordance with the provisions of Section&nbsp;242 of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Corporation has caused certificate to be signed on this
3<SUP STYLE="font-size:75%; vertical-align:top">rd</SUP>&nbsp;day of March, 2016. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ACADIA HEALTHCARE COMPANY, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher L. Howard</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Christopher L. Howard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive&nbsp;Vice&nbsp;President,&nbsp;General&nbsp;Counsel <BR>and Secretary</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE&nbsp;OF&nbsp;INCORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACADIA HEALTHCARE
COMPANY, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * * * </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Adopted in accordance with the provisions </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>of &#167;&#167;242 and 245 of the General Corporation Law </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>of the State of Delaware </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*
* * * * </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The undersigned, being the duly elected Executive Vice President, General Counsel and Secretary of Acadia Healthcare Company,
Inc., a corporation duly organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the &#147;<U>Corporation</U>&#148;), does hereby certify as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">That the Certificate of Incorporation of the Corporation was originally filed on May&nbsp;13, 2011. That the Certificate of Incorporation be,
and hereby is, amended and restated in its entirety to read as follows as set forth in the attached<U>&nbsp;Exhibit</U><U></U><U>&nbsp;A</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">That the Board of Directors of the Corporation approved the Amended and Restated Certificate of Incorporation by unanimous written consent
pursuant to the provisions of Section&nbsp;141(f) and&nbsp;242 of the General Corporation Law of the State of Delaware and directed that such amendment be submitted to the stockholders of the Corporation entitled to vote thereon for their
consideration, approval and adoption thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">That the stockholders entitled to vote thereon approved the Amended and Restated
Certificate of Incorporation by written consent in accordance with Section&nbsp;228, 242 and 245 of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned does hereby certify under penalties of perjury that this Amended and Restated Certificate of Incorporation
is the act and deed of the undersigned and the facts stated herein are true and accordingly has hereunto set his hand this 28<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>&nbsp;day of October, 2011. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ACADIA HEALTHCARE COMPANY, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Christopher L. Howard</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Christopher L. Howard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">EVP, General Counsel and Secretary</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE&nbsp;OF&nbsp;INCORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACADIA HEALTHCARE
COMPANY, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE ONE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of the Corporation is Acadia Healthcare Company, Inc. (the &#147;<U>Corporation</U>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE TWO </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The address
of the Corporation&#146;s registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, 19801. The name of its registered agent at such address is The Corporation Trust Company. Subject to the
applicable filing requirements of the General Corporation Law of the State of Delaware (the &#147;<U>DGCL</U>&#148;), the registered office and/or registered agent of the Corporation may be changed from time to time by resolution of the Board of
Directors of the Corporation (the &#147;<U>Board of Directors</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE THREE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The nature of the business of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the
General Corporation Law of the DGCL. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE FOUR </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PART A. AUTHORIZED SHARES </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
total number of shares of all classes of capital stock which the Corporation shall have authority to issue is 100,000,000 shares, consisting of: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. 10,000,000 shares of Preferred Stock, par value $0.01 per share (the &#147;<U>Preferred Stock</U>&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. 90,000,000 shares of Common Stock, par value $0.01 per share (the &#147;<U>Common Stock</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Preferred Stock and the Common Stock shall have the rights, preferences and limitations set forth below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PART B. PREFERRED STOCK </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors is authorized, subject to limitations prescribed by law, to provide by resolution or resolutions for the issuance of
shares of Preferred Stock in one or more series, and by filing a certificate pursuant to the DGCL, to establish the number of shares to be included in each such series, and to fix the voting powers (if any), designations, powers, preferences, and
relative, participating, optional or other rights, if any, of the shares of each such series, and any qualifications, limitations or restrictions thereof. Within the limitations or restrictions stated in any series of Preferred Stock, the Board of
Directors may increase or decrease (but not below the number of shares of any such series of Preferred Stock then outstanding) by resolution the number of shares of any such series of Preferred Stock. The number of authorized shares of Preferred
Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority in voting power of the outstanding shares of capital stock of the Corporation entitled to vote
thereon, without the separate vote of the holders of the Preferred Stock as a class irrespective of the provisions of Section&nbsp;242(b)(2) of the DGCL, unless a vote of any such holders is required pursuant to the terms of any Preferred Stock
designation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PART C. COMMON STOCK </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided by the DGCL or this Amended and Restated Certificate of Incorporation (this &#147;<U>Certificate of
Incorporation</U>&#148;) and subject to the terms of any series of Preferred Stock, all of the voting power of the stockholders of the Corporation shall be vested in the holders of the Common Stock. Each share of Common Stock shall entitle the
holder thereof to one vote for each share held by such holder on all matters voted upon by the stockholders of the Corporation;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that, except as otherwise required by the terms of any series of Preferred
Stock, holders of Common Stock, as such, shall not be entitled to vote on any amendment to this Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock) that relates solely to the terms of
one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to this Certificate of Incorporation
(including any certificate of designations relating to any series of Preferred Stock). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE FIVE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation is to have perpetual existence. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE SIX </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.&nbsp;<U>Board of Directors</U>. The business and affairs of the Corporation shall be managed by or under the direction of the
Board of Directors. In addition to the powers and authority expressly conferred upon them by statute or by this Certificate of Incorporation or the Bylaws of the Corporation, the directors are hereby empowered to exercise all such powers and do all
such acts and things as may be exercised or done by the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.&nbsp;<U>Number of Directors</U>. Subject to any rights of the holders of any
class or series of Preferred Stock to elect additional directors under specified circumstances, the number of directors which shall constitute the Board of Directors shall be fixed exclusively from time to time by resolution adopted by the
affirmative vote of a majority of the directors then in office. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.&nbsp;<U>Classes of Directors</U>. Beginning immediately
following the effective time of the merger of PHC, Inc. with and into a wholly-owned subsidiary of the Corporation (the &#147;<U>Effective Time</U>&#148;), the directors of the Corporation, other than those who may be elected by the holders of any
series of Preferred Stock under specified circumstances, shall be divided into three classes, hereby designated Class&nbsp;I, Class&nbsp;II and Class&nbsp;III (each a &#147;<U>Class</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.&nbsp;<U>Term of Office</U>. Subject to the terms of any series of Preferred Stock, the directors shall be elected by a
plurality of the votes of the shares present in person or represented by proxy at the meeting and entitled to vote in the election of directors;&nbsp;<U>provided</U>&nbsp;that, whenever the holders of one or more classes or series of capital stock
of the Corporation are entitled to elect, separated as a class, one or more directors pursuant to the provisions of this Certificate of Incorporation (including, but not limited to, any duly authorized certificate of designation), such directors
shall be elected by a plurality of the votes of such classes or series present in person or represented by proxy at the meeting and entitled to vote in the election of such directors. The term of office of the initial Class&nbsp;I directors shall
expire at the first succeeding annual meeting of stockholders after the Effective Time, the term of office of the initial Class&nbsp;II directors shall expire at the second succeeding annual meeting of stockholders after the Effective Time and the
term of office of the initial Class&nbsp;III directors shall expire at the third succeeding annual meeting of the stockholders after the Effective Time. For the purposes hereof, the Board of Directors may assign directors already in office to the
initial Class&nbsp;I, Class&nbsp;II and Class&nbsp;III at the Effective Time. At each annual meeting of stockholders after the Effective Time, directors elected to replace those of a Class&nbsp;whose terms expire at such annual meeting shall be
elected for a term expiring at the third succeeding annual meeting after their election and shall remain in office until their respective successors shall have been duly elected and qualified. After the Effective Time, each director shall hold
office until the annual meeting of stockholders for the year in which such director&#146;s term expires and a successor is duly elected and qualified or until his or her earlier death, resignation or removal. Nothing in this Certificate of
Incorporation shall preclude a director from serving consecutive terms. Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall so provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.&nbsp;<U>Newly-Created Directorships and Vacancies</U>. Subject to the rights of the holders of any series of Preferred Stock
then outstanding, newly created directorships resulting from any increase in the authorized number of directors or any vacancies in the Board of Directors resulting from death, resignation, disqualification, removal from office or any other cause
may be filled only by a majority of the directors then in office, although less than a quorum or by the sole remaining director. Notwithstanding the foregoing, to the fullest extent permitted by law, until such date as Waud Capital Partners, L.L.C.
and its affiliates (collectively, the &#147;<U>WCP Investors</U>&#148;) ceases to hold at least 17.5% of the outstanding Common Stock of the Corporation (such date, the &#147;<U>Trigger Date</U>&#148;), upon any vacancy in the Board of Directors for
any reason of a director designated by a person or persons in accordance with the terms of the Stockholders Agreement to be entered into by and between the Corporation and the Stockholders </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
party thereto on or about the Effective Time (as amended or restated from time to time, the &#147;<U>Stockholders Agreement</U>&#148;), the resulting vacancy on the Board of Directors shall be
filled by a representative designated by the person(s) entitled to designate such director pursuant to the Stockholders Agreement. Prior to the Effective Time, a director chosen to fill a vacancy or a position resulting from an increase in the
number of directors shall hold office until his or her successor is elected and qualified, or until his or her earlier death, resignation or removal. After the Effective Time, a director elected to fill a vacancy shall be elected for the unexpired
term of his or her predecessor in office and until his or her successor is elected and qualified, or until his or her earlier death, resignation or removal. After the Effective Time, a director chosen to fill a position resulting from an increase in
the number of directors shall hold office until the next election of the class for which such director shall have been chosen and until his or her successor is elected and qualified, or until his or her earlier death, resignation or removal. No
decrease in the authorized number of directors shall shorten the term of any incumbent director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.&nbsp;<U>Removal of
Directors</U>. Subject to the rights of the holders of any series of Preferred Stock then outstanding, to the fullest extent permitted by law, (i)&nbsp;until the Trigger Date, (a)&nbsp;a director designated by person(s) entitled to designate such
director in accordance with the Stockholders Agreement may be removed at any time, either for or without cause, only upon either (x)&nbsp;the affirmative vote of the holders of eighty percent (80%)&nbsp;of the voting power of the capital stock of
the Corporation outstanding and entitled to vote thereon or (y)&nbsp;if such director is being removed at the request of the person(s) entitled to designate such director in accordance with the Stockholders Agreement, by the affirmative vote of the
holders of a majority of the voting power of the stock outstanding and entitled to vote thereon and (b)&nbsp;a director not designated by person(s) entitled to designate such director in accordance with the Stockholders Agreement may be removed from
office only for cause and only by the affirmative vote of the holders of at least a majority of the voting power of the capital stock of the Corporation outstanding and entitled to vote thereon; and (ii)&nbsp;from and after the Trigger Date, a
director may be removed from office only for cause and only by the affirmative vote of the holders of at least a majority of the voting power of the capital stock of the Corporation outstanding and entitled to vote thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.&nbsp;<U>Bylaws</U>. In furtherance and not in limitation of the powers conferred upon it by the laws of the State of Delaware,
the Board of Directors shall have the power to adopt, amend, alter or repeal the Corporation&#146;s Bylaws. In addition to any other vote required by law, the affirmative vote of a majority of the directors then in office shall be required to adopt,
amend, alter or repeal the Corporation&#146;s Bylaws. The Corporation&#146;s Bylaws also may be adopted, amended, altered or repealed by the stockholders;&nbsp;<U>provided</U>, <U>however</U>, that in addition to any vote of the holders of any class
or series of stock of the Corporation required by law or by this Certificate of Incorporation, the affirmative vote of the holders of at least a majority of the voting power of all of the then outstanding shares of the capital stock of the
Corporation entitled to vote thereon, voting together as a single class shall be required for the stockholders to adopt, amend, alter or repeal any provisions of the Bylaws of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.&nbsp;<U>Advance Notice</U>. Advance notice of stockholder nominations for the election of directors and of business to be
brought by stockholders before any meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws of the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE SEVEN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the fullest extent permitted by the DGCL as it now exists or may hereafter be amended (but, in the case of any such amendment, only to the
extent that such amendment permits the Corporation to provide broader rights than permitted prior thereto), no director of the Corporation shall be liable to the Corporation or its stockholders for monetary damages arising from a breach of fiduciary
duty as a director. Any repeal or modification of the foregoing sentence shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification with respect to any act, omission or
other matter occurring prior to the time of such repeal or modification. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE EIGHT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Effective Time, the stockholders of the Corporation may take any action by written consent in lieu of a meeting, without prior
notice and without a vote, if a consent or consents in writing, setting forth the action so taken and bearing the dates of signature of the stockholders who signed the consent or consents, shall be signed by the holders of outstanding stock having
not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. On and after the Effective Time and subject to the rights of the
holders of any series of Preferred Stock, (i)&nbsp;(A) until such time as WCP Investors no longer beneficially own at least a majority of the outstanding Common Stock of the Corporation, the stockholders of the Corporation may take any action by
written consent in lieu of a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken and bearing the dates of signature of the stockholders who signed the consent or consents, shall be
signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and (B)&nbsp;after
such time, the stockholders may not take any action by written consent in lieu of a meeting, and must take any actions at a duly called annual or special meeting of stockholders and the power of stockholders to consent in writing without a meeting
is specifically denied; and (ii)&nbsp;special meetings of stockholders of the Corporation may be called only by a resolution adopted by the Board of Directors, by at least the affirmative vote of the majority of the directors then in office. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE NINE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.&nbsp;<U>Certain Acknowledgments</U>. In recognition of the fact that the Corporation, on the one hand, and the WCP Group (as
defined below), on the other hand, may currently engage in, and may in the future engage in, the same or similar activities or lines of business and have an interest in the same areas and types of corporate opportunities, and in recognition of the
benefits </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to be derived by the Corporation, through its continued corporate and business relations with the WCP Group (including possible service of directors, officers and employees of the WCP Group as
directors, officers and employees of the Corporation), the provisions of this ARTICLE NINE are set forth to regulate and define the conduct of certain affairs of the Corporation and its Affiliated Companies, as they may involve the WCP Group, the
powers, rights, duties and liabilities of the Corporation and its Affiliated Companies as well as the respective directors, officers, employees and stockholders thereof, and the powers, rights, duties and liabilities of the Corporation and its
directors, officers, employees and stockholders in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.&nbsp;<U>Renouncement of Certain Corporate
Opportunities</U>. To the fullest extent permitted by law: (i)&nbsp;the Corporation and its Affiliated Companies shall have no interest or expectancy in any corporate opportunity and no expectation that such corporate opportunity be offered to the
Corporation or its Affiliated Companies, if such opportunity is one that any member of the WCP Group has acquired knowledge of or is otherwise pursuing, and any such interest or expectancy in any such corporate opportunity is hereby renounced, so
that as a result of such renunciation, the corporate opportunity shall belong to the WCP Group; (ii)&nbsp;each member of the WCP Group shall have the right to, and shall have no duty (contractual or otherwise) not to, directly or indirectly:
(A)&nbsp;engage in the same, similar or competing business activities or lines of business as the Corporation or its Affiliated Companies, (B)&nbsp;do business with any client or customer of the Corporation or its Affiliated Companies, or
(C)&nbsp;make investments in competing businesses of the Corporation or its Affiliated Companies, and such acts shall not be deemed wrongful or improper; (iii)&nbsp;no member of the WCP Group shall be liable to the Corporation, its stockholders or
its Affiliated Companies for breach of any duty (contractual or otherwise), including without limitation fiduciary duties, by reason of any such activities or of such Person&#146;s participation therein; and (iv)&nbsp;in the event that any member of
the WCP Group acquires knowledge of a potential transaction or matter that may be a corporate opportunity for the Corporation or its Affiliated Companies, on the one hand, and any member of the WCP Group, on the other hand, or any other Person, no
member of the WCP Group shall have any duty (contractual or otherwise), including without limitation fiduciary duties, to communicate, present or offer such corporate opportunity to the Corporation or its Affiliated Companies and shall not be liable
to the Corporation, its stockholders or its Affiliated Companies for breach of any duty (contractual or otherwise), including without limitation fiduciary duties, by reason of the fact that any member of the WCP Group directly or indirectly pursues
or acquires such opportunity for itself, directs, sells, assigns or transfers such opportunity to another Person, or does not present or communicate such opportunity to the Corporation or its Affiliated Companies, even though such corporate
opportunity may be of a character that, if presented to the Corporation or its Affiliated Companies, could be taken by the Corporation or its Affiliated Companies. For the avoidance of doubt, nothing contained in the ARTICLE NINE shall prohibit the
Corporation and its Affiliated Companies from pursuing and/or executing any corporate opportunity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.&nbsp;<U>Certain
Definitions</U>. For purposes of this ARTICLE NINE, (i)&nbsp;&#147;<U>WCP Group</U>&#148; means Waud Capital Partners, L.L.C., its affiliates and any of their respective managed investment funds and portfolio companies (other than the Corporation
and its Affiliated Companies) and their respective partners, members, directors, employees, stockholders, agents, any successor by operation of law (including by merger) of any such person, and any entity that
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acquires all or substantially all of the assets of any such person in a single transaction or series of related transactions, in each case, whether or not any of the foregoing are serving as
directors or officers of the Corporation or any Affiliated Company; (ii)&nbsp;&#147;<U>Affiliated Company</U>&#148; means any company or entity controlled by the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.&nbsp;<U>Amendment of this Article</U>. Notwithstanding anything to the contrary elsewhere contained in this Certificate of
Incorporation: (i)&nbsp;the affirmative vote of the holders of at least eighty percent (80%)&nbsp;of the voting power of all shares of Common Stock then outstanding, voting together as a single class, shall be required to alter, amend or repeal, or
to adopt any provision inconsistent with, this ARTICLE NINE; (ii)&nbsp;neither the alteration, amendment or repeal of this ARTICLE NINE nor the adoption of any provision of this Amended and Restated Certificate of Incorporation inconsistent with
this ARTICLE NINE shall eliminate or reduce the effect of this ARTICLE NINE in respect of any matter occurring, or any cause of action, suit or claim that, but for this ARTICLE NINE, would accrue or arise, prior to such alteration, amendment, repeal
or adoption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.&nbsp;<U>Deemed Notice</U>. Any person or entity purchasing or otherwise acquiring any interest in any shares
of the Corporation shall be deemed to have notice of, and to have consented to, the provisions of this ARTICLE NINE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section
6.&nbsp;<U>Exception</U>. Notwithstanding the foregoing provisions of this ARTICLE NINE, the preceding provisions of this ARTICLE NINE shall not apply to any corporate opportunity which is expressly offered to a member of the WCP Group who is then a
director or officer of the Corporation if such corporate opportunity is offered to such person in writing solely in his or her capacity as an officer or director of the Corporation, and the Corporation does not renounce any interest or expectancy in
such opportunity. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE TEN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.&nbsp;<U>Section&nbsp;203 of the DGCL</U>. The Corporation expressly elects not to be governed by Section&nbsp;203 of the DGCL.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.&nbsp;<U>Interested Stockholder Transactions</U>. Notwithstanding any other provision in this Certificate of Incorporation
to the contrary, the Corporation shall not, after the Effective Time, engage in any Business Combination (as defined hereinafter) with any Interested Stockholder (as defined hereinafter) for a period of three years following the time that such
stockholder became an Interested Stockholder, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to such time the Board of Directors approved either the Business Combination or the transaction which
resulted in such stockholder becoming an Interested Stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">upon consummation of the transaction which resulted in such stockholder becoming an Interested Stockholder,
such stockholder owned at least eighty-five percent (85%)&nbsp;of the Voting Stock (as defined hereinafter) of the Corporation outstanding at the time the transaction commenced, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
excluding for purposes of determining the Voting Stock outstanding (but not the outstanding Voting Stock owned by such stockholder) those shares owned (i)&nbsp;by Persons (as defined hereinafter)
who are directors and also officers of the Corporation and (ii)&nbsp;employee stock plans of the Corporation in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in
a tender or exchange offer; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at or subsequent to such time the Business Combination is approved by the Board of Directors and authorized at
an annual or special meeting of stockholders by the affirmative vote of at least a majority of the outstanding Voting Stock which is not owned by such stockholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.&nbsp;<U>Exceptions to Prohibition on Interested Stockholder Transactions</U>. The restrictions contained in this ARTICLE TEN
shall not apply if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a stockholder becomes an Interested Stockholder inadvertently and (i)&nbsp;as soon as practicable divests
itself of ownership of sufficient shares so that the stockholder ceases to be an Interested Stockholder; and (ii)&nbsp;would not, at any time within the three-year period immediately prior to a Business Combination between the Corporation and such
stockholder, have been an Interested Stockholder but for the inadvertent acquisition of ownership; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Business Combination is proposed prior to the consummation or abandonment of and subsequent to the earlier
of the public announcement or the notice required hereunder of a proposed transaction which (i)&nbsp;constitutes one of the transactions described in the second sentence of this Section&nbsp;3(b) of this ARTICLE TEN; (ii)&nbsp;is with or by a Person
who either was not an Interested Stockholder during the previous three years or who became an Interested Stockholder with the approval of the Board of Directors; and (iii)&nbsp;is approved or not opposed by a majority of the directors then in office
(but not less than one) who were directors prior to any Person becoming an Interested Stockholder during the previous three years or were recommended for election or elected to succeed such directors by a majority of such directors. The proposed
transactions referred to in the preceding sentence are limited to (x)&nbsp;a merger or consolidation of the Corporation (except for a merger in respect of which, pursuant to &#167;&nbsp;251(f) of the DGCL, no vote of the stockholders of the
Corporation is required); (y)&nbsp;a sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of transactions), whether as part of a dissolution or otherwise, of assets of the Corporation or of any
direct or indirect majority-owned subsidiary of the Corporation (other than to any direct or indirect wholly-owned subsidiary or to the Corporation) having an aggregate market value equal to fifty percent (50%)&nbsp;or more of either that aggregate
market value of all of the assets of the Corporation determined on a consolidated basis or the aggregate </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
market value of all the outstanding Stock (as defined hereinafter) of the Corporation; or (z)&nbsp;a proposed tender or exchange offer for fifty percent (50%)&nbsp;or more of the outstanding
Voting Stock of the Corporation. The Corporation shall give not less than 20 days&#146; notice to all Interested Stockholders prior to the consummation of any of the transactions described in clause (x)&nbsp;or (y)&nbsp;of the second sentence of
this Section&nbsp;3(b) of this ARTICLE TEN. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.&nbsp;<U>Definitions</U>. As used in this ARTICLE TEN only, and
unless otherwise provided by the express terms of this ARTICLE TEN, the following terms shall have the meanings ascribed to them as set forth in this Section&nbsp;4 of this ARTICLE TEN: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Affiliate</U>&#148; means a Person that directly, or indirectly through one or more intermediaries,
controls, or is controlled by, or is under common control with, another Person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Associate</U>,&#148; when used to indicate a relationship with any Person, means: (i)&nbsp;any
corporation, partnership, unincorporated association or other entity of which such Person is a director, officer or partner or is, directly or indirectly, the owner of twenty percent (20%)&nbsp;or more of any class of Voting Stock; (ii)&nbsp;any
trust or other estate in which such Person has at least a twenty percent (20%)&nbsp;beneficial interest or as to which such Person serves as trustee or in a similar fiduciary capacity; and (iii)&nbsp;any relative or spouse of such Person, or any
relative of such spouse, who has the same residence as such Person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Business Combination</U>&#148; means: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any merger or consolidation of the Corporation or any direct or indirect majority-owned subsidiary of the
Corporation with (A)&nbsp;the Interested Stockholder, or (B)&nbsp;with any Person if the merger or consolidation is caused by the Interested Stockholder and as a result of such merger or consolidation Section&nbsp;2 of this ARTICLE TEN is not
applicable to the surviving entity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of
transactions), except proportionately as a stockholder of the Corporation, to or with the Interested Stockholder, whether as part of a dissolution or otherwise, of assets of the Corporation or of any direct or indirect majority-owned subsidiary of
the Corporation which assets have an aggregate market value equal to ten percent (10%)&nbsp;or more of either the aggregate market value of all the assets of the Corporation determined on a consolidated basis or the aggregate market value of all the
outstanding Stock of the Corporation; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any transaction or series of transactions which results in the issuance or transfer by the Corporation or by
any direct or indirect majority-owned subsidiary of the Corporation of ten percent (10%)&nbsp;or more of any class or series of Stock of the Corporation or of such subsidiary to the Interested Stockholder, except: (A)&nbsp;pursuant to the exercise,
exchange or conversion of securities exercisable for, exchangeable for or convertible into Stock of the Corporation or any such subsidiary which securities were outstanding prior to the time that the Interested Stockholder became such;
(B)&nbsp;pursuant to a merger under &#167;&nbsp;251(g) or &#167;&nbsp;253 of the DGCL; (C)&nbsp;pursuant to a dividend or distribution paid or made, or the exercise, exchange or conversion of securities exercisable for, exchangeable for or
convertible into Stock of the Corporation or any such subsidiary which security is distributed, pro rata to all holders of a class or series of Stock of the Corporation subsequent to the time the Interested Stockholder became such; or
(D)&nbsp;pursuant to an exchange offer by the Corporation to purchase Stock made on the same terms to all holders of such Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Control</U>,&#148; including the terms &#147;<U>controlling</U>,&#148; &#147;<U>controlled
by</U>&#148; and &#147;<U>under common control with</U>,&#148; means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of stock or other
equity interests, by contract or otherwise. A Person who is the owner of twenty percent (20%)&nbsp;or more of the outstanding Voting Stock of any corporation, partnership, unincorporated association or other entity shall be presumed to have control
of such entity, in the absence of proof by a preponderance of the evidence to the contrary; notwithstanding the foregoing, a presumption of control shall not apply where such Person holds Voting Stock, in good faith and not for the purpose of
circumventing this ARTICLE TEN, as an agent, bank, broker, nominee, custodian or trustee for one or more owners who do not individually or as a group have control of such entity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Interested Stockholder</U>&#148; means any Person (other than the Corporation and any direct or
indirect majority-owned subsidiary of the Corporation) that (i)&nbsp;is the owner of fifteen percent (15%)&nbsp;or more of the outstanding Voting Stock of the Corporation, or (ii)&nbsp;is an Affiliate or Associate of the Corporation and was the
owner of fifteen percent (15%)&nbsp;or more of the outstanding Voting Stock of the Corporation at any time within the three-year period immediately prior to the date on which it is sought to be determined whether such Person is an Interested
Stockholder, and the Affiliates and Associates of such Person. Notwithstanding anything in this ARTICLE TEN to the contrary, the term &#147;<U>Interested Stockholder</U>&#148; shall not include: (x)&nbsp;Waud Capital Partners, L.L.C. or any
investment fund managed by Waud Capital Partners, L.L.C. or any of their respective Affiliates or Associates from time to time and any other person or entity with whom any of the foregoing are acting as a group or in concert for the purpose of
acquiring, holding, voting or disposing of shares of stock of the Corporation; (y)&nbsp;any Person who would otherwise be an Interested </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Stockholder because of a transfer, sale, assignment, conveyance, hypothecation, encumbrance, or other disposition of five percent (5%)&nbsp;or more of the outstanding Voting Stock of the
Corporation (in one transaction or a series of transactions) by any party specified in the immediately preceding clause (x)&nbsp;to such Person;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that such Person was not an Interested Stockholder prior to
such transfer, sale, assignment, conveyance, hypothecation, encumbrance, or other disposition; or (z)&nbsp;any Person whose ownership of shares in excess of the fifteen percent (15%)&nbsp;limitation set forth herein is the result of action taken
solely by the Corporation,&nbsp;<U>provided</U>&nbsp;that, for purposes of this clause (z), such Person shall be an Interested Stockholder if thereafter such Person acquires additional shares of Voting Stock of the Corporation, except as a result of
further action by the Corporation not caused, directly or indirectly, by such Person;&nbsp;<U>provided</U>&nbsp;further that, for purposes of clause (x), if (i)&nbsp;Waud Capital Partners, L.L.C., any investment fund managed by Waud Capital
Partners, L.L.C. and any of their respective Affiliates or Associates are in the aggregate the owners of less than fifteen percent (15%)&nbsp;of the outstanding Voting Stock of the Corporation and (ii)&nbsp;thereafter any such Person becomes the
owner of fifteen percent (15%)&nbsp;or more of the outstanding Voting Stock of the Corporation, such Person shall then be an Interested Stockholder;&nbsp;<U>provided</U> further that, for purposes of clause (y)&nbsp;if (i)&nbsp;after any such Person
becomes the owner of fifteen percent (15%)&nbsp;or more of the outstanding Voting Stock of the Corporation as provided in clause (y), and (ii)&nbsp;such Person becomes the owner of less than fifteen percent (15%)&nbsp;of the outstanding Voting Stock
of the Corporation, then such Person thereafter becomes the owner of fifteen percent (15%)&nbsp;or more of the outstanding Voting Stock of the Corporation, such Person shall then be an Interested Stockholder; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Owner</U>,&#148; including the terms &#147;<U>own</U>&#148; and &#147;<U>owned</U>,&#148; when used
with respect to any Stock, means a Person that individually or with or through any of its Affiliates or Associates beneficially owns such Stock, directly or indirectly; or has (A)&nbsp;the right to acquire such Stock (whether such right is
exercisable immediately or only after the passage of time) pursuant to any agreement, arrangement or understanding, or upon the exercise of conversion rights, exchange rights, warrants or options, or
otherwise;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that a Person shall not be deemed the owner of Stock tendered pursuant to a tender or exchange offer made by such Person or any of such Person&#146;s Affiliates or Associates until such tendered
Stock is accepted for purchase or exchange; or (B)&nbsp;the right to vote such Stock pursuant to any agreement, arrangement or understanding;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that a Person shall not be deemed the owner of any Stock because
of such Person&#146;s right to vote such Stock if the agreement, arrangement or understanding to vote such Stock arises solely from a revocable proxy or consent given in response to a proxy or consent solicitation made to ten (10)&nbsp;or more
Persons; or has any agreement, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
arrangement or understanding for the purpose of acquiring, holding, voting (except voting pursuant to a revocable proxy or consent as described in (B)&nbsp;of this Section&nbsp;4(f) of ARTICLE
TEN), or disposing of such Stock with any other Person that beneficially owns, or whose Affiliates or Associates beneficially own, directly or indirectly, such Stock;<U>&nbsp;provided</U>, that, for the purpose of determining whether a Person is an
Interested Stockholder, the Voting Stock of the Corporation deemed to be outstanding shall include Stock deemed to be owned by the Person through application of this definition of &#147;owned&#148; but shall not include any other unissued Stock of
the Corporation which may be issuable pursuant to any agreement, arrangement or understanding, or upon exercise of conversion rights, warrants or options, or otherwise; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Person</U>&#148; means any individual, corporation, partnership, unincorporated association or other
entity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Stock</U>&#148; means, with respect to any corporation, capital stock and, with respect to any other
entity, any equity interest; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Voting Stock</U>&#148; means, with respect to any corporation, Stock of any class or series entitled
to vote generally in the election of directors and, with respect to any entity that is not a corporation, any equity interest entitled to vote generally in the election of the governing body of such entity. Every reference to a percentage of Voting
Stock shall refer to such percentage of the votes of such Voting Stock. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE ELEVEN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or before the third anniversary of the Effective Date, neither the Corporation nor any of its direct or indirect subsidiaries shall adopt
or otherwise implement any &#147;poison pill&#148; stockholder rights plan, or issue, sell or otherwise distribute any rights or securities to any person pursuant to such a plan, without first obtaining the approval of the holders of a majority of
the voting power of the capital stock of the Corporation then outstanding. Any action taken in contravention of the preceding sentence shall be null and void. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE TWELVE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed herein and by the laws of the State of Delaware, and all rights conferred upon
stockholders herein are granted subject to this reservation. Notwithstanding any other provision of this Certificate of Incorporation or the Bylaws of the Corporation, and notwithstanding the fact that a lesser percentage or separate class vote may
be specified by law or otherwise, but in addition to any affirmative vote of the holders of any particular class or series of the capital stock required by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
law or otherwise, the affirmative vote of the holders of at least a majority of the voting power of all outstanding shares of capital stock of the Corporation entitled to vote thereon, other than
shares owned by any Interested Stockholder, shall, voting together as a single class, be required to adopt any provision inconsistent with, to amend, alter, change or repeal any provision of ARTICLE SIX, SEVEN, EIGHT, TEN, ELEVEN, TWELVE, THIRTEEN
or FOURTEEN of this Certificate of Incorporation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE THIRTEEN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be
the sole and exclusive forum for (i)&nbsp;any derivative action or proceeding brought on behalf of the Corporation, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any director or officer of the Corporation to the
Corporation or the Corporation&#146;s stockholders, (iii)&nbsp;any action asserting a claim against the Corporation arising pursuant to any provision of the Delaware General Corporation Law or the Corporation&#146;s Certificate of Incorporation <FONT
STYLE="white-space:nowrap">or&nbsp;by-laws&nbsp;or</FONT> (iv)&nbsp;any action asserting a claim against the Corporation governed by the internal affairs doctrine. Any person or entity purchasing or otherwise acquiring any interest in shares of
capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this ARTICLE THIRTEEN. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE
FOURTEEN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that any provision of this Certificate of Incorporation is found to be invalid or unenforceable, such
invalidity or unenforceability shall not affect the validity or enforceability of any other provision of this Certificate of Incorporation, and following any determination by a court of competent jurisdiction that any provision of this Certificate
of Incorporation is invalid or unenforceable, this Certificate of Incorporation shall contain only such provisions (i)&nbsp;as were in effect immediately prior to such determination and (ii)&nbsp;were not so determined to be invalid or
unenforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&#8195;*&#8195;*&#8195;*&#8195;* </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d833064dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EMPLOYMENT AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS EMPLOYMENT AGREEMENT (this &#147;<U>Agreement</U>&#148;) is made and entered into as of May&nbsp;23, 2024 (the &#147;<U>Effective
Date</U>&#148;), by and between Acadia Management Company, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), and Nasser Khan (&#147;<U>Executive</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">WHEREAS,&nbsp;the Company desires to continue to employ Executive, and Executive desires to continue to be employed by and render services to
the Company and its respective affiliates, on the terms and conditions set forth in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of
the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&#8195;<U>Employment; Employment Period</U>. The Company shall continue to employ Executive, and Executive hereby accepts continued
employment with the Company, upon the terms and conditions set forth in this Agreement for the period beginning on June&nbsp;30, 2024 (the &#147;<U>Start Date</U>&#148;) and ending on the date on which Executive&#146;s employment is terminated
pursuant to <U>Section</U><U></U><U>&nbsp;4</U> hereof (the &#147;<U>Employment Period</U>&#148;). It is anticipated that Executive will work remotely from the Portland, Oregon area during the Employment Period; <U>provided</U>, that Executive will
be required to travel from time to time on Company business during the Employment Period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&#8195;<U>Position and Duties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Position; Responsibilities</U>. During the Employment Period, Executive shall serve as the Chief Operating Officer of the Company
and Acadia Healthcare Company, Inc., a Delaware corporation (&#147;<U>Acadia</U>&#148;) and shall have the normal duties, responsibilities, functions and authority of chief operating officer, subject to the power and authority of the board of
directors (the &#147;<U>Board</U>&#148;) of Acadia, to expand or limit such duties, responsibilities, functions and authority within the scope of duties, responsibilities, functions and authority associated with the position of Chief Operating
Officer and to overrule actions of officers of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Reporting; Performance of Duties</U>. Executive shall report to
the Chief Executive Officer of Acadia and devote Executive&#146;s full business time and attention (except for permitted vacation periods and reasonable periods of illness or other incapacity) to the business and affairs of Acadia and the
Subsidiaries. So long as Executive is employed by the Company, Executive shall not, without the prior written consent or approval of the Board, perform other services for compensation. Notwithstanding the foregoing, nothing herein shall preclude
Executive from (i)&nbsp;serving, with the prior written consent of the Board (not to be unreasonably withheld), as a member of the boards of directors or advisory boards (or their equivalents in the case of a
<FONT STYLE="white-space:nowrap">non-corporate</FONT> entity) of <FONT STYLE="white-space:nowrap">for-profit</FONT> companies or businesses which are not directly competitive with the Company or any Subsidiary (provided that the prior written
consent of the Board shall not be required for Executive to serve as a member of the boards of directors or advisory boards (or their equivalents) of the companies listed on <U>Exhibit A</U>) or (ii)&nbsp;engaging in charitable activities and
community affairs (including serving as a member of the boards of directors or advisory boards (or their equivalents in the case of a <FONT STYLE="white-space:nowrap">non-corporate</FONT> entity) of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">not-for-profit,</FONT></FONT> charitable or community organizations which are not directly competitive with the Company or any Subsidiary); </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provided, however, the activities set out in clauses (i)&nbsp;and (ii)&nbsp;above shall be limited by Executive so as not to materially interfere, individually or in the aggregate, with the
performance of Executive&#146;s duties and responsibilities hereunder. For the avoidance of doubt, so long as Executive is employed by the Company, Executive shall not provide any services to any company or business that is directly competitive with
Acadia or the Subsidiaries (whether <FONT STYLE="white-space:nowrap">for-profit</FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit)</FONT></FONT> without the prior written consent of the Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&#8195;<U>Compensation and Benefits</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Base Salary</U>. During the Employment Period, Executive&#146;s base salary shall be $515,000 per annum, subject to increase by
the Board or Acadia&#146;s Compensation Committee (the &#147;<U>Compensation Committee</U>&#148;) in its sole discretion on an annual basis (as adjusted from time to time, the &#147;<U>Base Salary</U>&#148;), which salary shall be payable by the
Company in regular installments in accordance with the Company&#146;s general payroll practices (as in effect from time to time). The Base Salary for any partial year during the Employment Period will be based upon the actual number of days elapsed
in such year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Bonus</U>. In addition to the Base Salary, during each calendar year of the Employment Period beginning with
the year ending December&nbsp;31, 2024, Executive will be eligible to earn a target annual cash bonus of 85% of the Base Salary and up to a maximum cash bonus equal to two (2)&nbsp;times the target annual cash bonus for such year, if and only if
Executive, Acadia and the Subsidiaries achieve the performance criteria specified by the Board or the Compensation Committee for such year, as determined by the Board or the Compensation Committee in its sole discretion. Notwithstanding the
foregoing, Executive&#146;s Annual Bonus for the 2024 calendar year will be equitably blended based on Executive&#146;s target bonus in effect immediately before the Start Date and that in effect for the balance of the performance year. Unless
otherwise agreed to by Executive, any such bonus amount for any year shall be earned (if awarded) on the last day of such year and paid by the Company in the calendar year following the calendar year to which such bonus has been earned and no later
than the earlier of (x)&nbsp;the date that is ten (10)&nbsp;business days after the Company&#146;s receipt of its audited financial statements for the calendar year with respect to which such bonus has been earned and (y)&nbsp;December&nbsp;31 of
the calendar year following such year with respect to which such bonus has been earned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;<U>Long-Term Incentive
Compensation</U>. Executive shall be eligible to receive annual grants of long-term incentive awards in amounts and on terms and conditions comparable to Acadia&#146;s other senior executives as determined by the Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;<U>Business Expenses</U>. During the Employment Period, the Company shall reimburse Executive
<FONT STYLE="white-space:nowrap">bi-weekly</FONT> in accordance with the Company&#146;s customary payroll practices for all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> business expenses
incurred by Executive in the course of performing Executive&#146;s duties and responsibilities under this Agreement that are consistent with the Company&#146;s policies in effect from time to time with respect to travel, lodging, meals,
entertainment and other business expenses, subject to the Company&#146;s requirements with respect to reporting and documentation of such expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&#8195;<U>Benefits</U>. In addition to (but without duplication of) the Base Salary and any bonuses payable to Executive pursuant to this
<U>Section</U><U></U><U>&nbsp;3</U>, Executive shall be entitled to participate at Executive&#146;s sole discretion in all of the Company&#146;s employee benefit programs for which senior executive employees of the Company are generally eligible.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&#8195;<U>Termination</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Termination</U>. The Employment Period shall terminate automatically and immediately upon Executive&#146;s resignation for any
reason (whether with Good Reason or without Good Reason), Executive&#146;s death or becoming Disabled, or upon the termination of Executive&#146;s employment by the Company (through action by the Board) for any reason (whether for Cause or without
Cause). The date on which Executive ceases to be employed by the Company is referred to herein as the &#147;<U>Termination Date</U>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Termination without Cause or with Good Reason</U>. If the Employment Period is terminated by the Company without Cause or by
Executive with Good Reason, then Executive shall be entitled to receive: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&#8195;Executive&#146;s unpaid Base Salary through the
Termination Date (payable in accordance with <U>Section</U><U></U><U>&nbsp;3(a)</U>, or such earlier date required by law); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;an amount equal to the actual annual cash bonus amount to which Executive would be entitled under
<U>Section</U><U></U><U>&nbsp;3(b)</U> with respect to the calendar year in which the Termination Date occurs, determined based on achievement of the performance objectives specified in Executive&#146;s bonus plan for such year, as determined by the
Board or the Compensation Committee in its sole discretion, which amount shall be prorated based on the actual number of days elapsed in such year prior to the Termination Date (payable at the same time it would have been paid pursuant to
<U>Section</U><U></U><U>&nbsp;3(b)</U>); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&#8195;an amount equal to one (1)&nbsp;times the target annual cash bonus amount to which
Executive would be entitled under <U>Section</U><U></U><U>&nbsp;3(b)</U> with respect to the calendar year in which the Termination Date occurs, determined as if Executive, Acadia and the Subsidiaries have achieved all of the performance objectives
specified in Executive&#146;s bonus plan for such year at the target level, whether or not such objectives actually have been achieved as of the Termination Date (payable in a lump sum within ten (10)&nbsp;business days after the Termination Date);
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&#8195;an amount equal to twelve (12)&nbsp;months of Executive&#146;s Base Salary as in effect on the Termination Date (such <FONT
STYLE="white-space:nowrap">12-month</FONT> period, the &#147;<U>Severance Period</U>&#148;), (payable in a lump sum within ten (10)&nbsp;business days after the Termination Date); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)&#8195;payment of the Annual Bonus for the prior year, to the extent not previously paid; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi)&#8195;payment in respect of any unused paid time off and sick pay of Executive in such amounts as have accrued as of the Termination
Date in accordance with the Company&#146;s policies with respect thereto as in effect during the Employment Period, and reimbursement of any business expenses incurred by Executive but not reimbursed prior to the Termination Date in accordance with
and reimbursable under the terms of the Company&#146;s policies with respect thereto as in effect on the Termination Date (in each case, payable in a lump sum within ten (10)&nbsp;business days after the Termination Date); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii)&#8195;an amount equal to the cost of the premiums for continued health and dental
insurance for Executive and/or Executive&#146;s dependents in accordance with the Consolidated Budget Reconciliation Act of 1985 (&#147;<U>COBRA</U>&#148;) for the period commencing on the Termination Date and ending on the date on which the
Severance Period expires (payable in monthly installments during and concurrently with Executive&#146;s COBRA period); provided that if Executive&#146;s COBRA period is terminated or expires prior to expiration of the Severance Period, then
Executive shall be entitled to continue to receive an amount equal to the cost of the premiums for continued health and dental insurance for Executive and/or Executive&#146;s dependents in accordance with COBRA (assuming such continued insurance
coverage remained available at the same monthly cost) for the period commencing on the date of such termination or expiration and ending on the date on which the Severance Period expires; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii)&#8195;all equity and equity-based awards granted to Executive during the Employment Period (the &#147;<U>Equity Awards</U>&#148;)
shall be treated as set forth below: (A)&nbsp;the Equity Awards subject to time-based vesting requirements will fully vest on the Termination Date; and (B)&nbsp;the Equity Awards subject to performance-based vesting requirements will remain
outstanding and eligible to vest based on actual achievement of the applicable performance conditions, subject to the terms and conditions (other than any term or condition requiring continued employment) set forth in the applicable award agreement
and/or governing documentation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, Executive shall not be entitled to receive the benefits provided for in <U>Sections
4(b)(ii) &#150; 4(b)(viii)</U> above unless and until Executive signs and delivers and does not revoke the General Release substantially in the form attached hereto as <U>Exhibit B</U>; and <U>provided further</U> that Executive has not breached any
of the provisions of <U>Sections 5, 6 and 7</U> hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;<U>Termination by Death or Disability</U>. If the Employment Period is
terminated due to Executive&#146;s death or becoming Disabled, then Executive (or Executive&#146;s estate or beneficiary) shall be entitled to receive: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&#8195;Executive&#146;s unpaid Base Salary through the Termination Date (payable in accordance with
<U>Section</U><U></U><U>&nbsp;3(a)</U>); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;an amount equal to the actual annual cash bonus amount to which Executive would be
entitled under <U>Section</U><U></U><U>&nbsp;3(b)</U> with respect to the calendar year in which the Termination Date occurs, determined based on achievement of the performance objectives specified in Executive&#146;s bonus plan for such year, as
determined by the Board or the Compensation Committee in its sole discretion, which amount shall be prorated based on the actual number of days elapsed in such year prior to the Termination Date (payable at the same time it would have been paid
pursuant to <U>Section</U><U></U><U>&nbsp;3(b)</U>); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&#8195;payment in respect of any unused paid time off and sick pay of
Executive in such amounts as have accrued as of the Termination Date in accordance with the Company&#146;s policies with respect thereto as in effect during the Employment Period, and reimbursement of any business expenses incurred by Executive but
not reimbursed prior to the Termination Date in accordance with and reimbursable under the terms of the Company&#146;s policies with respect thereto as in effect on the Termination Date (in each case, payable in a lump sum within ten
(10)&nbsp;business days after the Termination Date); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&#8195;an amount equal to the cost of the premiums for continued health and dental
insurance for Executive and/or Executive&#146;s dependents in accordance with COBRA for the period commencing on the Termination Date and ending on the earliest of (A)&nbsp;the date on which Executive&#146;s COBRA period terminates or expires,
(B)&nbsp;six (6)&nbsp;months after the Termination Date, and (C)&nbsp;the date on which Executive becomes eligible for long-term disability benefits under any long-term disability program sponsored by the Company (payable in monthly installments
during and concurrently with Executive&#146;s COBRA period); provided that if Executive&#146;s COBRA period is terminated prior to expiration of the period commencing on the Termination Date and ending on the earlier of (I)&nbsp;the date on which
Executive becomes eligible for long-term disability benefits under any long-term disability program sponsored by the Company, and (II)&nbsp;six (6)&nbsp;months after the Termination Date (such period, the &#147;<U>Disability Severance
Period</U>&#148;), then Executive shall be entitled to continue to receive an amount equal to the cost of the premiums for continued health and dental insurance for Executive and/or Executive&#146;s dependents in accordance with COBRA (assuming such
continued insurance coverage remained available at the same monthly cost) payable in monthly installments during the period commencing on the date of such termination or expiration and ending on the date on which the Disability Severance Period
expires; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)&#8195;payment of the Annual Bonus under <U>Section</U><U></U><U>&nbsp;3(b)</U> for the prior year, to the extent not
previously paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if the Employment Period is terminated due to Executive&#146;s becoming Disabled (but, for the avoidance of doubt, not due
to Executive&#146;s death), then Executive (or Executive&#146;s estate or beneficiary) shall be entitled to receive, during the Disability Severance Period, continued installment payments of Executive&#146;s Base Salary as in effect on the
Termination Date, which shall be payable over the Disability Severance Period in regular installments in accordance with the Company&#146;s general payroll practices as in effect on the Termination Date, but in no event less frequently than monthly.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;<U>Other Termination</U>. If the Employment Period is terminated (i)&nbsp;by the Company for Cause, or (ii)&nbsp;by
Executive&#146;s resignation without Good Reason, then the Company shall pay Executive (A)&nbsp;Executive&#146;s unpaid Base Salary through the Termination Date (payable in accordance with <U>Section</U><U></U><U>&nbsp;3(a)</U>) and (B)&nbsp;payment
of the Annual Bonus for the prior year to the extent not paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&#8195;<U>Continuation of Benefits</U>. Upon any termination of
employment, whether voluntary or otherwise, Executive shall have the option to elect health insurance coverage for Executive, Executive&#146;s spouse and Executive&#146;s eligible dependents during the period commencing on the end of the statutory
COBRA period, if any (provided that Executive validly elected COBRA continuation coverage), until the earliest of the date on which Executive (A)&nbsp;is eligible to participate in another health benefit plan (including, without limitation, a plan
sponsored by a then current or former employer of Executive&#146;s or Executive&#146;s spouse, other than a plan that provides for &#147;excepted benefits&#148; as defined under section 733(c) of the Employee Retirement Income Security Act of 1974)
or (B)&nbsp;becomes eligible for Medicare. Such coverage will be provided for by the Company (or any successor to the Company, whether by operation of law or otherwise) in accordance with applicable law, and Executive shall pay premiums consistent
with other senior executive employees of the Company (or any successor to the Company, whether by operation of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
law or otherwise). Executive agrees to take all required actions and provide any requested personal medical history and information, in accordance with the applicable policy application and
medical underwriting process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&#8195;<U>No Mitigation</U>. Executive is under no obligation to mitigate damages or the amount of any
payment provided for under this <U>Section</U><U></U><U>&nbsp;4</U> by seeking other employment or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&#8195;<U>Right of
Offset</U>. The Company may offset any bona fide obligations that Executive owes Acadia or any of the Subsidiaries (which for the avoidance of doubt shall not include any unliquidated obligations or obligations to the extent Executive disputes in
good faith the nature or amount thereof) against any amounts the Company or any of the Subsidiaries owes Executive hereunder; provided that, notwithstanding the foregoing or any other provision of this Agreement to the contrary, in no event shall
any payment under this Agreement that constitutes &#147;deferred compensation&#148; for purposes of Code Section&nbsp;409A be subject to offset, counterclaim or recoupment by any other amount unless otherwise permitted by Code Section&nbsp;409A.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&#8195;<U>Section</U><U></U><U>&nbsp;409A Compliance</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&#8195;The intent of the parties is that payments and benefits under this Agreement comply with Section&nbsp;409A of the Internal Revenue
Code of 1986, as amended (the &#147;<U>Code</U>&#148;) and the regulations and guidance promulgated thereunder (collectively &#147;<U>Code Section</U><U></U><U>&nbsp;409A</U>&#148;) and, accordingly, to the maximum extent permitted, this Agreement
shall be interpreted and administered to be in compliance therewith. In no event whatsoever shall Acadia or any of the Subsidiaries be liable for any additional tax, interest or penalty that may be imposed on Executive by Code Section&nbsp;409A or
damages for failing to comply with Code Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;A termination of employment shall not be deemed to have occurred
for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a &#147;separation from service&#148; within the meaning of Code
Section&nbsp;409A and, for purposes of any such provision of this Agreement, references to a &#147;termination,&#148; &#147;termination of employment,&#148; &#147;termination of the Employment Period&#148; or like terms shall mean &#147;separation
from service.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&#8195;All expenses or other reimbursements under this Agreement shall be made on or prior to the last day of
the taxable year following the taxable year in which such expenses were incurred by Executive (provided that if any such reimbursements constitute taxable income to Executive, such reimbursements shall be paid no later than March 15th of the
calendar year following the calendar year in which the expenses to be reimbursed were incurred), and no such reimbursement or expenses eligible for reimbursement in any taxable year shall in any way affect the expenses eligible for reimbursement in
any other taxable year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&#8195;For purposes of Code Section&nbsp;409A, Executive&#146;s right to receive any installment payment
pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)&#8195;Whenever a
payment under this Agreement specifies a payment period with reference to a number of days (<I>e.g.</I>, &#147;payment shall be made within fifteen (15)&nbsp;days following the Termination Date&#148;), the actual date of payment within the specified
period shall be within the sole discretion of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi)&#8195;Notwithstanding any other payment schedule provided herein to the contrary, if
Executive is deemed on the Termination Date to be a &#147;specified employee&#148; within the meaning of that term under Code Section&nbsp;409A(a)(2)(B), then any payment that is considered deferred compensation under Code Section&nbsp;409A payable
on account of a &#147;separation from service&#148; shall be made on the date which is the earlier of (a)&nbsp;the expiration of the six (6)-month period measured from the date of such &#147;separation from service&#148; of Executive and
(b)&nbsp;the date of Executive&#146;s death (the &#147;<U>Delay Period</U>&#148;) to the extent required under Code Section&nbsp;409A. Upon the expiration of the Delay Period, all payments delayed pursuant to the immediately preceding sentence
(whether they otherwise would have been payable in a single sum or in installments in the absence of such delay) shall be paid to Executive in a lump sum, and all remaining payments due under this Agreement shall be paid or provided in accordance
with the normal payment dates specified for them herein. In addition, if Executive is a &#147;specified employee,&#148; to the extent that welfare benefits to be provided to Executive pursuant to this Agreement are not &#147;disability pay,&#148;
&#147;death benefit&#148; plans or <FONT STYLE="white-space:nowrap">non-taxable</FONT> medical benefits within the meaning of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(a)(5)</FONT> or other benefits not considered
nonqualified deferred compensation within the meaning of that regulation, such provision of benefits shall be delayed until the end of the Delay Period. Notwithstanding the foregoing, to the extent that the previous sentence applies to the provision
of any ongoing health or welfare benefits that would not be required to be delayed if the premiums were paid by Executive, Executive shall pay the full cost of the premiums for such benefits during the Delay Period and the Company shall pay
Executive an amount equal to the amount of such premiums paid by Executive during the Delay Period within ten (10)&nbsp;days after the end of the Delay Period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&#8195;<U>Confidential Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Protection of Confidential Information</U>. Executive acknowledges that the continued success of Acadia and the Subsidiaries
depends upon the use and protection of a large body of confidential and proprietary information. All of such confidential and proprietary information now existing or to be developed in the future will be referred to in this Agreement as
&#147;<U>Confidential Information</U>.&#148; Confidential Information will be interpreted broadly to include, without limitation, all information that is (i)&nbsp;related to Acadia&#146;s or the Subsidiaries&#146; (including any of their
predecessors&#146; prior to being acquired by the Company) current or potential business and (ii)&nbsp;is not generally or publicly known (including, without specific limitation, the information, observations and data concerning (A)&nbsp;acquisition
opportunities in or reasonably related to Acadia&#146;s or the Subsidiaries&#146; business or industry, (B)&nbsp;identities and requirements of, contractual arrangements with and other information regarding Acadia&#146;s or the Subsidiaries&#146;
employees (including personnel files and other information), suppliers, distributors, customers, independent contractors, third-party payors, providers or other business relations and their confidential information, including, without limitation,
patient records, medical histories and other information concerning patients (including, without limitation, all &#147;Protected Health Information&#148; within the meaning of the Health Insurance Portability and Accountability Act), and
(C)&nbsp;internal business information and intellectual property of every kind and description of Acadia and the Subsidiaries). Executive agrees that during the Employment Period and at any time thereafter, Executive shall not disclose to any
unauthorized person or use for Executive&#146;s own account any of such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Confidential Information, whether or not developed by Executive, without the Board&#146;s prior written consent, unless and to the extent that any Confidential Information (1)&nbsp;was known to
Executive prior to the negotiation of this Agreement or the Employment Period from a source (other than Acadia, the Subsidiaries or any of their respective agents) that, to the knowledge of Executive, was not prohibited from disclosing such
information by a legal, contractual or fiduciary obligation to Acadia or any of the Subsidiaries, (2)&nbsp;becomes generally known to and available for use by the public other than as a result of Executive&#146;s acts or omissions to act or
(3)&nbsp;is required to be disclosed pursuant to any applicable law or court order. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Use of Others&#146; Confidential
Information</U>. During the Employment Period, Executive shall not use or disclose any confidential information or trade secrets, if any, of any former employers or any other Person to whom Executive has an obligation of confidentiality. If at any
time during Executive&#146;s employment with the Company, Executive believes Executive is being asked to engage in work that will, or will be likely to, jeopardize any confidentiality or other obligations Executive may have to former employers, then
Executive shall immediately advise the Board so that Executive&#146;s duties can be modified appropriately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;<U>Third-Party
Information</U>. Executive understands that Acadia and the Subsidiaries will receive from third parties confidential or proprietary information (&#147;<U>Third-Party Information</U>&#148;) subject to a duty on Acadia&#146;s and the
Subsidiaries&#146; part to maintain the confidentiality of such information and to use it only for certain limited purposes. During the Employment Period and thereafter, and without in any way limiting the provisions of
<U>Section</U><U></U><U>&nbsp;5(a)</U>, Executive will hold Third-Party Information in the strictest confidence and will not disclose to anyone (other than personnel of Acadia or the Subsidiaries who need to know such information in connection with
their work for Acadia or the Subsidiaries) or use, except in connection with&nbsp;Executive&#146;s work for Acadia or the Subsidiaries, Third-Party Information unless expressly authorized by the Board in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;<U>Whistleblower Protection</U>. Notwithstanding anything to the contrary contained herein, no provision of this Agreement will be
interpreted so as to impede Executive (or any other individual) from (i)&nbsp;making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this Agreement, or as required by law or
legal process, including with respect to possible violations of law, (ii)&nbsp;participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency, legislative body or any
self-regulatory organization, including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, (iii)&nbsp;accepting any U.S. Securities and Exchange Commission Awards,
or (iv)&nbsp;making other disclosures under the whistleblower provisions of federal law or regulation. In addition, nothing in this Agreement or any other agreement or Company policy prohibits or restricts Executive from initiating communications
with, or responding to any inquiry from, any administrative, governmental, regulatory or supervisory authority regarding any good faith concerns about possible violations of law or regulation. Executive does not need the prior authorization of the
Company to make any such reports or disclosures and Executive will not be required to notify the Company that such reports or disclosures have been made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&#8195;<U>Ownership of Intellectual Property, Inventions and Patents</U>. Executive
acknowledges that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, processes, programs, designs, analyses, drawings, reports, patent applications, copyrightable work and mask work (whether or not
including any confidential information) and all registrations or applications related thereto, all other proprietary information and all similar or related information (whether or not patentable) which relate to Acadia&#146;s or the
Subsidiaries&#146; actual or anticipated business, research and development or existing or future products or services and which are conceived, developed, contributed to, made or reduced to practice by Executive (whether alone or jointly with
others) while employed by Acadia or the Subsidiaries after the date of this Agreement, including any of the foregoing that constitutes any proprietary information or records (&#147;<U>Work Product</U>&#148;), belong to Acadia or such Subsidiary. Any
copyrightable work prepared in whole or in part by Executive in the course of Executive&#146;s work for any of the foregoing entities shall be deemed a &#147;work made for hire&#148; to the maximum extent permitted under copyright laws, and Acadia
or such Subsidiary shall own all rights therein. To the extent any such copyrightable work is not a &#147;work made for hire,&#148; Executive hereby assigns and agrees to assign to Acadia or such Subsidiary all right, title and interest, including,
without limitation, copyright, in and to such copyrightable work. Executive shall promptly disclose such Work Product to the Board and, at the Company&#146;s expense, perform all actions reasonably requested by the Board (whether during or after the
Employment Period) to establish and confirm such ownership by Acadia or such Subsidiary (including, without limitation, execution and delivery of assignments, consents, powers of attorney and other instruments). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&#8195;<U><FONT STYLE="white-space:nowrap">Non-Compete;</FONT> <FONT STYLE="white-space:nowrap">Non-Solicit</FONT></U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U><FONT STYLE="white-space:nowrap">Non-Compete</FONT></U>. In further consideration of the compensation to be paid to Executive
hereunder, Executive acknowledges that, during the course of Executive&#146;s employment with the Company, Executive has and shall become familiar with Acadia&#146;s and the Subsidiaries&#146; trade secrets and with other Confidential Information
concerning Acadia and the Subsidiaries and that Executive&#146;s services have been and shall be of special, unique and extraordinary value to Acadia and the Subsidiaries, and, therefore, Executive agrees that, during the Employment Period and for a
period thereafter of twelve (12)&nbsp;months (the &#147;<U>Noncompete Period</U>&#148;), Executive shall not (i)&nbsp;directly or indirectly own any interest in, manage, control, participate in, consult with, render services for, or in any manner
engage in any business that derives at least 25% of its gross revenue from the business of providing behavioral healthcare and/or related services or (ii)&nbsp;directly or indirectly manage, control, participate in, consult with or render services
specifically with respect to any unit, division, segment or subsidiary of any other business that engages in or otherwise competes with (or was organized for the purpose of engaging in or competing with) the business of providing behavioral
healthcare and/or related services (provided that, this clause (ii)&nbsp;shall not be construed to prohibit Executive from directly or indirectly owning any interest in, managing, controlling, participating in, consulting with, rendering services
for, or in any manner engaging in any business activities with or for such business generally and, for the avoidance of doubt, not specifically with respect to such unit, division, segment or subsidiary), in each case, within any geographical area
in which Acadia and the Subsidiaries engage in such businesses; provided that Executive shall not be subject to the restrictions set forth in this <U>Section</U><U></U><U>&nbsp;7(a)</U> if the Employment Period is terminated by the Company without
Cause or by Executive with Good Reason and for so long as the Company is in breach of its obligations under <U>Section</U><U></U><U>&nbsp;4(b)</U> and such breach is not the subject of a good faith dispute between the Company and Executive. For
purposes of this Agreement, the term &#147;participate in&#148; shall include, without limitation, having any direct or indirect interest in any Person, whether as a sole proprietor, owner, stockholder, partner, joint venturer,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
creditor or otherwise, or rendering any direct or indirect service or assistance to any individual, corporation, partnership, joint venture and other business entity (whether as a director,
officer, manager, supervisor, employee, agent, consultant or otherwise). Nothing herein shall prohibit Executive from being a passive owner of not more than 2% of the outstanding stock of any class of a corporation which is publicly traded, so long
as Executive has no active participation in the business of such corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U><FONT STYLE="white-space:nowrap">Non-Solicit</FONT></U>. During the Employment Period and for a period thereafter of twelve
(12)&nbsp;months (the &#147;<U>Nonsolicit Period</U>&#148;), Executive shall not directly or indirectly through another Person (other than on behalf of Acadia and the Subsidiaries) (i)&nbsp;induce or attempt to induce any employee or independent
contractor of Acadia or the Subsidiaries to leave the employ or services of Acadia or the Subsidiaries, or in any way interfere with the relationship between Acadia and the Subsidiaries and any employee or independent contractor thereof,
(ii)&nbsp;hire or seek any business affiliation with any person who was an employee or independent contractor of Acadia or the Subsidiaries at any time during the twelve (12)&nbsp;months prior to the Termination Date or (iii)&nbsp;induce or attempt
to induce any customer, supplier, licensee, licensor or other business relation of Acadia or any Subsidiary to cease doing business with Acadia or such Subsidiary or interfere with the relationship between any such customer, supplier, licensor or
other business relation and Acadia or any Subsidiary; provided that Executive shall not be subject to the restrictions set forth in this <U>Section</U><U></U><U>&nbsp;7(b)</U> if the Employment Period is terminated by the Company without Cause or by
Executive with Good Reason and for so long as the Company is in breach of its obligations under <U>Section</U><U></U><U>&nbsp;4(b)</U> and such breach is not the subject of a good faith dispute between the Company and Executive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;<U><FONT STYLE="white-space:nowrap">Non-Disparagement</FONT></U>. Without limiting any other obligation of Executive pursuant to
this Agreement, Executive hereby covenants and agrees that, except as may be required by applicable law, Executive shall not make any statement, written or verbal, in any forum or media, or take any other action in disparagement of Acadia or any of
its Subsidiaries, during the Employment Period and for a period of five (5)&nbsp;years thereafter (the &#147;<U><FONT STYLE="white-space:nowrap">Non-Disparagement</FONT> Period</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;<U>Blue-Pencil</U>. If, at the time of enforcement of <U>Section</U><U></U><U>&nbsp;5</U> or <U>6</U> or this
<U>Section</U><U></U><U>&nbsp;7</U>, a court shall hold that the duration, scope or area restrictions stated herein are unreasonable under circumstances then existing, the parties agree that the maximum duration, scope or area reasonable under such
circumstances shall be substituted for the stated duration, scope or area and that the court shall be allowed to revise the restrictions contained herein to cover the maximum duration, scope and area permitted by law. Executive hereby acknowledges
and represents that Executive has either consulted with independent legal counsel regarding Executive&#146;s rights and obligations under this Agreement or knowingly and voluntarily waived the opportunity to do so and that Executive fully
understands the terms and conditions contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&#8195;<U>Additional Acknowledgments</U>. Executive acknowledges that the
provisions of <U>Sections 5</U> and <U>6</U> and this <U>Section</U><U></U><U>&nbsp;7</U> are in consideration of Executive&#146;s employment with the Company and other good and valuable consideration as set forth in this Agreement. In addition,
Executive agrees and acknowledges that the restrictions contained in <U>Sections 5</U> and <U>6</U> and this <U>Section</U><U></U><U>&nbsp;7</U> do not preclude Executive from earning a livelihood, nor do they unreasonably impose
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
limitations on Executive&#146;s ability to earn a living. In addition, Executive acknowledges (x)&nbsp;that the business of Acadia and the Subsidiaries will be conducted throughout the United
States and its territories and beyond, (y)&nbsp;notwithstanding the state of organization or principal office of Acadia or any of the Subsidiaries or facilities, or any of their respective executives or employees (including Executive), it is
expected that Acadia and the Subsidiaries will have business activities and have valuable business relationships within its industry throughout the United States and its territories and beyond, and (z)&nbsp;as part of Executive&#146;s
responsibilities, Executive will be traveling throughout the United States and other jurisdictions where Acadia and the Subsidiaries conduct business during the Employment Period in furtherance of the Company&#146;s business relationships. Executive
agrees and acknowledges that the potential harm to Acadia and the Subsidiaries of the <FONT STYLE="white-space:nowrap">non-enforcement</FONT> of any provision of <U>Sections 5</U> and <U>6</U> and this <U>Section</U><U></U><U>&nbsp;7</U> outweighs
any potential harm to Executive of its enforcement by injunction or otherwise. Executive acknowledges that Executive has carefully read this Agreement and either consulted with legal counsel of Executive&#146;s choosing regarding its contents or
knowingly and voluntarily waived the opportunity to do so, has given careful consideration to the restraints imposed upon Executive by this Agreement and is in full accord as to their necessity for the reasonable and proper protection of
confidential and proprietary information of Acadia and the Subsidiaries now existing or to be developed in the future. Executive expressly acknowledges and agrees that each and every restraint imposed by this Agreement is reasonable with respect to
subject matter, duration and geographical area. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&#8195;<U>Specific Performance</U>. In the event of the breach or a threatened breach
by Executive of any of the provisions of <U>Section</U><U></U><U>&nbsp;5</U> or <U>6</U> or this <U>Section</U><U></U><U>&nbsp;7</U>, Acadia and the Subsidiaries would suffer irreparable harm and that money damages would not be a sufficient remedy
and, in addition and supplementary to other rights and remedies existing in its favor whether under this Agreement or under any other agreement, the Company shall be entitled to specific performance and/or injunctive or other equitable relief from a
court of competent jurisdiction in order to enforce or prevent any violations of the provisions hereof (without posting a bond or other security). In addition, in the event of an alleged breach or violation by Executive of this
<U>Section</U><U></U><U>&nbsp;7</U>, the Noncompete Period or the Nonsolicit Period, as applicable, shall be tolled until such breach or violation has been duly cured. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&#8195;<U>Executive&#146;s Representations</U>. Executive hereby represents and warrants to the Company that (a)&nbsp;the execution,
delivery and performance of this Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree to which Executive is a party or by which Executive
is bound, (b)&nbsp;except as previously disclosed to the Company in writing (a copy of each such agreement having been provided to the Company prior to the Effective Date or being publicly available on EDGAR as of the Effective Date), Executive is
not a party to or bound by any employment agreement, noncompete agreement or confidentiality agreement with any other person or entity, (c)&nbsp;except as previously disclosed to the Company in writing, Executive took nothing with Executive which
belonged to any former employer when Executive left Executive&#146;s prior position and Executive has nothing that contains any information which belongs to any former employer, in either case which would reasonably be likely to result in any
liability to Acadia or any Subsidiary, and (d)&nbsp;upon the execution and delivery of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in accordance with its terms. Executive hereby
acknowledges and represents that Executive has either consulted with independent legal counsel regarding Executive&#146;s rights and obligations under this Agreement or knowingly and voluntarily waived the opportunity to do so and that Executive
fully understands the terms and conditions contained herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&#8195;<U>Definitions</U>. For purposes of this Agreement, the following terms shall have
the meanings set forth below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cause</U>&#148; shall mean with respect to Executive one or more of the following: (i)&nbsp;the
conviction of or plea of nolo contendere to a felony or other crime involving moral turpitude or the conviction of any crime involving misappropriation, embezzlement or fraud with respect to Acadia or any of the Subsidiaries or any of their
customers, suppliers or other business relations, (ii)&nbsp;conduct outside the scope of Executive&#146;s duties and responsibilities under this Agreement that causes Acadia or any of the Subsidiaries substantial public disgrace or disrepute or
economic harm, (iii)&nbsp;repeated failure to perform duties consistent with this Agreement as reasonably directed by the Board, (iv)&nbsp;any act or knowing omission aiding or abetting a competitor, supplier or customer of Acadia or any of the
Subsidiaries to the disadvantage or detriment of Acadia and the Subsidiaries, (v)&nbsp;breach of fiduciary duty, gross negligence or willful misconduct with respect to Acadia or any of the Subsidiaries, (vi)&nbsp;an administrative or other
proceeding results in the suspension or debarment of Executive from participation in any contracts with, or programs of, the United States or any of the fifty states or any agency or department thereof, or (vii)&nbsp;any other material breach by
Executive of this Agreement or any other agreement between Executive and Acadia or any of the Subsidiaries, which is not cured to the Board&#146;s reasonable satisfaction within thirty (30)&nbsp;days after written notice thereof to Executive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disabled</U>&#148; means any physical or mental disability or infirmity that has prevented the performance of Executive&#146;s duties
for a period of (a)&nbsp;one hundred twenty (120)&nbsp;consecutive days or (b)&nbsp;one hundred eighty <FONT STYLE="white-space:nowrap">(180)&nbsp;non-consecutive</FONT> days during any twelve (12)-month period. Any question as to the existence,
extent or potentiality of Executive&#146;s Disability upon which Executive and the Company cannot agree shall be determined by a qualified, independent physician selected by the Company and reasonably approved by Executive (or Executive&#146;s
representative). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Good Reason</U>&#148; shall mean if Executive resigns Executive&#146;s employment with the Company as a result
of one or more of the following actions (in each case taken without Executive&#146;s written consent): (i)&nbsp;a reduction in Executive&#146;s Base Salary; (ii)&nbsp;a material diminution of Executive&#146;s job duties or responsibilities
inconsistent with Executive&#146;s position, which shall include, without limitation, Executive&#146;s removal from the position specified in <U>Section</U><U></U><U>&nbsp;2(a),</U> or the Company&#146;s hiring an individual at an equivalent or
senior level to Executive to perform substantially the same duties and responsibilities set forth in <U>Section</U><U></U><U>&nbsp;2(a)</U>, or assigning job duties or responsibilities materially inconsistent with Executive&#146;s position;
(iii)&nbsp;any other material breach by the Company or Acadia (or their successors) of this Agreement; or (iv)&nbsp;a required relocation of Executive&#146;s principle place of employment; provided that, none of the events described in clauses
(i)&nbsp;through (iv)&nbsp;above shall constitute Good Reason unless Executive shall have notified the Company and/or Acadia in writing describing the event which constitutes Good Reason within ninety (90)&nbsp;days after the occurrence of such
event and then only if the Company and/or Acadia and the Subsidiaries shall have failed to cure such event within thirty (30)&nbsp;days after the Company&#146;s and/or Acadia&#146;s receipt of such written notice and Executive elects to terminate
Executive&#146;s employment as a result at the end of such thirty (30)&nbsp;day period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; shall mean an individual, a partnership, a corporation (whether or
not for profit), a limited liability company, an association, a joint stock company, a trust, a joint venture, or other business entity, an unincorporated organization and a governmental entity or any department, agency or political subdivision
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; shall mean any corporation or other entity of which the securities or other ownership interests
having the voting power to elect a majority of the board of directors or other governing body are, at the time of determination, owned by Acadia or of which Acadia serves as the managing member or in a similar capacity or of which Acadia holds a
majority of the partnership or limited liability company or similar interests or is otherwise entitled to receive a majority of distributions made by it, in each case directly or through one or more Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&#8195;<U>Survival</U>. Except as otherwise provided in <U>Section</U><U></U><U>&nbsp;4(d)</U>, <U>Sections 4</U> through <U>27</U> (other
than <U>Section</U><U></U><U>&nbsp;22</U>) shall survive and continue in full force in accordance with their terms notwithstanding the expiration or termination of the Employment Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&#8195;<U>Notices</U>. Any notice provided for in this Agreement shall be in writing and shall be personally delivered, sent by facsimile
(with hard copy to follow), sent by reputable overnight courier service, or mailed by first class mail, return receipt requested, to the recipient at the address below indicated: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notices to Executive: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nasser
Khan </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At the address on the books and records of the Company at the time of such notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Notices to the Company: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Acadia
Healthcare Company, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">6100 Tower Circle, Suite 1000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Franklin, TN 37067 Attention: Board of Directors </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;(615) <FONT STYLE="white-space:nowrap">261-9685</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">with copies (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Acadia Healthcare Company, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">6100 Tower Circle, Suite 1000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Franklin, TN 37067 Attention: General Counsel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;(615) <FONT STYLE="white-space:nowrap">261-9685</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or such other address or to the attention of such other Person as the recipient party shall have specified by prior written notice to the sending party. Any
notice under this Agreement shall be deemed to have been given when so delivered or sent by facsimile (subject to automatic proof of transmission), one day after being sent by overnight courier or three days after being mailed by first class mail,
return receipt requested, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&#8195;<U>Severability</U>. Whenever possible, each provision of this Agreement shall be
interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision of this Agreement or any action in any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal
or unenforceable provision had never been contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&#8195;<U>Complete Agreement</U>. This Agreement and those documents
expressly referred to herein embody the complete agreement and understanding among the parties with respect to, and supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral, which may
have related to, the subject matter hereof in any way. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&#8195;<U>No Strict Construction</U>. The language used in this Agreement shall
be deemed to be the language chosen by the parties hereto to express their mutual intent, and no rule of strict construction shall be applied against any party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&#8195;<U>Counterparts</U>. This Agreement may be executed in separate counterparts (including by means of facsimile or by electronic
transmission in portable document format (pdf) or comparable electronic transmission), each of which is deemed to be an original and all of which taken together constitute one and the same agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&#8195;<U>Successors and Assigns</U>. This Agreement is personal in nature and neither of the parties hereto shall, without the consent of
the other, assign, transfer or delegate this Agreement or any rights or obligations hereunder; provided that (i)&nbsp;this Agreement will inure to the benefit of and be enforceable by Executive&#146;s personal or legal representatives, executors,
administrators, successors, heirs, distributees and legatees (but otherwise will not otherwise be assignable, transferable or delegable by Executive), and (ii)&nbsp;this Agreement will be assignable, transferable or delegable by the Company, without
the consent of Executive, to Acadia or any of the Subsidiaries or to any successor (whether direct or indirect, in whatever form of transaction) to all or substantially all of the business or assets of the Company or Acadia or the Subsidiaries (none
of which shall constitute a termination of Executive&#146;s employment hereunder). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&#8195;<U>Choice of Law and Forum</U>. All issues
and questions concerning the construction, validity, enforcement and interpretation of this Agreement and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving
effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. The parties agree that
any dispute arising out of or relating to this Agreement, exclusively shall be brought in the state courts located in Williamson County, Tennessee or the United States District Court for the Middle District of Tennessee. Each party hereby waives any
objection to the personal or subject matter jurisdiction and venue of such courts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&#8195;<U>Amendment and Waiver</U>. The provisions
of this Agreement may be amended or waived only with the prior written consent of the Company (as approved by the Board) and Executive, and no course of conduct or course of dealing or failure or delay by any party hereto in enforcing or exercising
any of the provisions of this Agreement (including, without limitation, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company&#146;s right to terminate the Employment Period for Cause) shall affect the validity, binding effect or enforceability of this Agreement or be deemed to be an implied waiver of any
provision of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.&#8195;<U>Insurance</U>. The Company may, at its discretion, apply for and procure in its own name and
for its own benefit life and/or disability insurance on Executive in any amount or amounts considered advisable. Executive agrees to cooperate in any medical or other examination, supply any information and execute and deliver any applications or
other instruments in writing as may be reasonably necessary to obtain and constitute such insurance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.&#8195;<U>Indemnification and
Reimbursement of Payments on Behalf of Executive</U>. Acadia and the Subsidiaries shall be entitled to deduct or withhold from any amounts owing from Acadia or any of the Subsidiaries to Executive any federal, state, local or foreign withholding
taxes, excise tax, or employment taxes (&#147;<U>Taxes</U>&#148;) imposed with respect to Executive&#146;s compensation or other payments from Acadia or any of the Subsidiaries or Executive&#146;s ownership interest in Acadia or any of the
Subsidiaries (including, without limitation, wages, bonuses, dividends, the receipt or exercise of equity options and/or the receipt or vesting of restricted equity), as may be required to be deducted or withheld by any applicable law or regulation.
In the event Acadia or any of the Subsidiaries does not make such deductions or withholdings, Executive shall indemnify Acadia and the Subsidiaries for any amounts paid with respect to any such Taxes, together (if such failure to withhold was at the
written direction of Executive or if Executive was informed in writing by Acadia or such Subsidiary that such deductions or withholdings were not made) with any interest, penalties and related expenses thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.&#8195;<U>Waiver of Jury Trial</U>. AS A SPECIFICALLY BARGAINED FOR INDUCEMENT FOR EACH OF THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT
(AFTER HAVING THE OPPORTUNITY TO CONSULT WITH COUNSEL), EACH PARTY HERETO EXPRESSLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY LAWSUIT OR PROCEEDING RELATING TO OR ARISING IN ANY WAY FROM THIS AGREEMENT OR THE MATTERS CONTEMPLATED HEREBY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22.&#8195;<U>Opportunity</U>. During the Employment Period, Executive shall submit to the Board all investment or business opportunities of
which Executive becomes aware and which are within the scope and investment objectives of Acadia or any of the Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.&#8195;<U>Executive&#146;s Cooperation</U>. During the Employment Period Executive shall cooperate with Acadia and the Subsidiaries in any
internal investigation or administrative, regulatory or judicial investigation or proceeding or any dispute with any third party as reasonably requested by Acadia or the Subsidiaries (including, without limitation, Executive being available to
Acadia and the Subsidiaries upon reasonable notice for interviews and factual investigations, appearing at Acadia&#146;s or any of the Subsidiaries&#146; request to give testimony without requiring service of a subpoena or other legal process,
volunteering Acadia and the Subsidiaries all pertinent information and turning over to Acadia and the Subsidiaries all relevant documents which are or may come into Executive&#146;s possession, all at times and on schedules that are reasonably
consistent with Executive&#146;s other permitted activities and commitments), all at Acadia&#146;s or the Subsidiaries&#146; sole cost and expense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24.&#8195;<U>Delivery by Facsimile or PDF</U>. This Agreement, the agreements referred to
herein, and each other agreement or instrument entered into in connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto, to the extent signed and delivered by means of a facsimile machine or electronic
transmission in pdf, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. At the
request of any party hereto or to any such agreement or instrument, each other party hereto or thereto shall <FONT STYLE="white-space:nowrap">re-execute</FONT> original forms thereof and deliver them to all other parties. No party hereto or to any
such agreement or instrument shall raise the use of a facsimile machine or electronic transmission in pdf to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile
machine or electronic transmission in pdf as a defense to the formation or enforceability of a contract and each such party forever waives any such defense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25.&#8195;<U>Indemnification and Directors and Officers Insurance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;During the Employment Period and for a period of six (6)&nbsp;years thereafter, the Company shall, to the fullest extent permitted
under applicable law, indemnify and hold harmless Executive against all costs and expenses (including attorneys&#146; fees), judgments, fines, losses, claims, damages, liabilities and settlement amounts paid in connection with any claim, action,
suit, proceeding or investigation (whether arising before or after the Effective Date), whether civil, criminal, administrative or investigative, arising out of or pertaining to any action or omission in their capacity as an officer, director,
employee, fiduciary or agent of the Company (or Acadia or any Subsidiary). In the event of any such claim, action, suit, proceeding or investigation, (i)&nbsp;the Company shall pay the reasonable fees and expenses of counsel selected by Executive
promptly after statements therefor are received, (ii)&nbsp;neither the Company, Acadia nor any Subsidiary shall settle, compromise or consent to the entry of any judgment in any pending or threatened action to which Executive is a party (and in
respect of which indemnification could be sought by Executive hereunder), unless such settlement, compromise or consent includes an unconditional release of Executive from all liability arising out of such action, or Executive otherwise consents
(which consent shall not be unreasonably withheld, conditioned or delayed), and (iii)&nbsp;the Company, Acadia and the applicable Subsidiaries shall cooperate in the defense of any such matter. In the event that any claim for indemnification is
asserted or made within the Employment Period or the six (6)&nbsp;year period thereafter, all rights of Executive to indemnification in respect of such claim shall continue until the final disposition of such claim. The rights of Executive under
this <U>Section</U><U></U><U>&nbsp;25(a)</U> shall be in addition to any rights Executive may have under the organizational documents of the Company, Acadia or any Subsidiary, under any law, or under any agreement of Executive with the Company,
Acadia or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;During the Employment Period and for a period of six (6)&nbsp;years thereafter, the Company, or any
successor to the Company, shall purchase and maintain, at its own expense, directors and officers liability insurance providing coverage for Executive in the same or greater amount as for members of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26.&#8195;<U>Legal Fees and Expenses</U>. In the event any litigation or other court action, arbitration or similar adjudicatory proceeding (a
&#147;<U>Proceeding</U>&#148;) is commenced or threatened by any party hereto (the &#147;<U>Claiming Party</U>&#148;) to enforce its rights under this Agreement against any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other party hereto (the &#147;<U>Defending Party</U>&#148;), if the Defending Party is the prevailing party in such Proceeding, all fees, costs and expenses, including, without limitation,
reasonable attorneys fees and court costs, incurred by the Defending Party in such Proceeding, will be reimbursed by the Claiming Party, and, if the Claiming Party is the prevailing party in such Proceeding, all fees, costs and expenses, including,
without limitation, reasonable attorneys fees and court costs, incurred by the Claiming Party in such Proceeding, will be reimbursed by the Defending Party; provided that if the Defending Party prevails in part, and loses in part, in such
Proceeding, the court, arbitrator or other adjudicator presiding over such Proceeding shall award a reimbursement of the fees, costs and expenses incurred by the Claiming Party and the Defending Party on an equitable basis. For purposes of this
<U>Section</U><U></U><U>&nbsp;26</U>, and without limiting the generality of the foregoing, the Defending Party will be deemed to have prevailed in any Proceeding if the Claiming Party commences or threatens such Proceeding and (i)&nbsp;the
underlying claim(s) in such Proceeding are subsequently dropped or dismissed, or (ii)&nbsp;the Defending Party defeats any such claim(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27.&#8195;<U>Acadia Guarantee</U>. Acadia unconditionally guarantees and promises to pay and perform, upon Executive&#146;s demand following a
default by the Company, any and all obligations of the Company from time to time owed to Executive under this Agreement, subject to any applicable cure period. Acadia further agrees that if the Company shall fail to fulfill any of its obligations
under this Agreement, Acadia will perform the same on demand as a principal obligor, and not as a surety. This is a continuing guarantee of the obligations and may not be revoked and shall not otherwise terminate unless and until the obligations of
the Company have been paid and performed in full. Acadia represents and warrants that it will receive a substantial benefit from Company&#146;s employment of Executive, which employment gives rise to the obligations of the Company under this
Agreement. Acadia acknowledges that Executive would not execute this Agreement if it did not receive this guarantee. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>*&#8195;&#8195;&#8195;*&#8195;&#8195;&#8195;*&#8195;&#8195;&#8195; *&#8195;&#8195;&#8195;* </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the
date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">COMPANY:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ACADIA MANAGEMENT COMPANY, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Hunter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Christopher Hunter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">EXECUTIVE:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nasser Khan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Nasser Khan</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ACKNOWLEDGED AND AGREED:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACADIA HEALTHCARE COMPANY, INC.,<BR></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">solely with respect to Sections 7 and 27</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Hunter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Christopher Hunter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Board Service </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GENERAL RELEASE<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">I, Nasser Khan, in consideration of and subject to the performance by Acadia Management Company, Inc., a Delaware corporation (together with
its affiliates, the &#147;<U>Compan</U>y&#148;), of the Company&#146;s obligations under the Employment Agreement dated as of June&nbsp;30, 2023 (the &#147;<U>Agreement</U>&#148;), do hereby release and forever discharge as of the date hereof the
Company and all present, former and future managers, directors, officers, employees, successors and assigns of the Company and direct or indirect owners (collectively, the &#147;<U>Released Parties</U>&#148;) to the extent provided below (this
&#147;<U>General Release</U>&#148;). The Released Parties are intended to be third-party beneficiaries of this General Release, and this General Release may be enforced by each of them in accordance with the terms hereof in respect of the rights
granted to such Released Parties hereunder. Terms used herein but not otherwise defined shall have the meanings given to them in the Agreement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I understand that any payments or benefits paid or granted to me under Section&nbsp;4 of the Agreement
represent, in part, consideration for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive certain of the payments and benefits specified in
Section&nbsp;4, unless I execute this General Release and do not revoke this General Release within the time period permitted hereafter. Such payments and benefits will not be considered compensation for purposes of any employee benefit plan,
program, policy or arrangement maintained or hereafter established by the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except as provided in paragraphs 5 and 6 below and except for the provisions of the Agreement which expressly
survive the termination of my employment with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns) release and forever discharge the Company and the other Released Parties from any and all claims,
suits, controversies, actions, causes of action, cross-claims, counter-claims, demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys&#146; fees, or liabilities of any
nature whatsoever in law and in equity, both past and present (through the date that this General Release becomes effective and enforceable) and whether known or unknown, suspected, or claimed against the Company or any of the Released Parties which
I, my spouse, or any of my heirs, executors, administrators or assigns, may have, including those that arise out of or are connected with my employment with, or my separation or termination from, the Company (including, but not limited to, any
allegation, claim or violation, arising under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act);
the Equal Pay Act of 1963, as amended; the Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the Employee Retirement Income Security Act of 1974; any applicable
Executive Order Programs; the Fair Labor Standards Act; or their state or local counterparts; or under any other federal, state or local civil or human </P></TD></TR></TABLE>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Note to Draft</U>: Subject to updates to the extent necessary for applicable governing law.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
rights law, or under any other&nbsp;local, state, or federal law, regulation or ordinance; or under any public policy, contract or tort, or under common law; or arising under any policies,
practices or procedures of the Company; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any claim for costs, fees, or other expenses, including attorneys&#146; fees incurred in these matters)
(all of the foregoing collectively referred to herein as the &#147;<U>Claims</U>&#148;). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The released claims described in paragraph 2 hereof include all such claims, whether known or unknown by me.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I represent that I have made no assignment or transfer of any right, claim, demand, cause of action, or other
matter covered by paragraph 2 above. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I agree that this General Release does not waive or release any rights or claims that I may have under the Age
Discrimination in Employment Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation from employment with the Company in compliance with the terms of the Agreement shall not serve as the
basis for any claim or action (including, without limitation, any claim under the Age Discrimination in Employment Act of 1967). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I agree that I hereby waive all rights to sue or obtain equitable, remedial or punitive relief from any or all
Released Parties of any kind whatsoever in respect of any Claim, including, without limitation, reinstatement, back pay, front pay, and any form of injunctive relief. Notwithstanding the above, I further acknowledge that I am not waiving and am not
being required to waive any right that cannot be waived under law, including the right to file an administrative charge or participate in an administrative investigation or proceeding; provided, however, that I disclaim and waive any right to share
or participate in any monetary award resulting from the prosecution of such charge or investigation or proceeding, other than any such award to which I become entitled pursuant to Section&nbsp;922 of the Dodd-Frank Wall Street Reform and Consumer
Protection Act or awards under other whistleblower laws that cannot be waived by law. Additionally, I am not waiving (and nothing set forth herein shall be deemed a release of)&nbsp;(a) any right to any earned and accrued salary, vacation, benefits,
expense reimbursements, or any severance benefits to which I am entitled under the Agreement, (b)&nbsp;any claim relating to directors&#146; and officers&#146; liability insurance coverage or any right of indemnification under the Company&#146;s
organizational documents, applicable law or otherwise, including, without limitation, Sections 25 and 26 of the Agreement, (c)&nbsp;claims for workers&#146; compensation benefits under any of the Company&#146;s workers&#146; compensation insurance
policies or funds, (d)&nbsp;claims related to my rights under the Consolidated Budget Reconciliation Act of 1985, as amended and/or (e)&nbsp;any obligations of the Company under this General Release, including my rights to enforce this General
Release. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In signing this General Release, I acknowledge and intend that it shall be effective as a bar to each and every
one of the Claims hereinabove mentioned or implied. I expressly consent that this General Release shall be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected
Claims (notwithstanding any state or local statute that expressly limits the effectiveness of </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those relating to any other Claims hereinabove mentioned or implied. I acknowledge and agree that this
waiver is an essential and material term of this General Release and that without such waiver the Company would not have agreed to the terms of the Agreement. I further agree that in the event I should bring a Claim seeking damages against the
Company, or in the event I should seek to recover against the Company in any Claim brought by a governmental agency on my behalf, this General Release shall serve as a complete defense to such Claims to the maximum extent permitted by law.&nbsp;I
further agree that I am not aware of any pending claim of the type described in paragraph 2 above as of the execution of this General Release. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I agree that neither this General Release, nor the furnishing of the consideration for this General Release,
shall be deemed or construed at any time to be an admission by the Company, any Released Party or myself of any improper or unlawful conduct. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I agree that if I violate this General Release by suing the Company or the other Released Parties, I will pay
all costs and expenses of defending against the suit incurred by the Released Parties, including reasonable attorneys&#146; fees. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any <FONT STYLE="white-space:nowrap">non-disclosure</FONT> provision in this General Release does not prohibit
or restrict me (or my attorney) from responding to any inquiry about this General Release or its underlying facts and circumstances by the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other
self-regulatory organization or any governmental entity. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I hereby acknowledge that Sections 4 through 27 (other than Section&nbsp;22) of the Agreement shall survive my
execution of this General Release. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I represent that I am not aware of any claim by me other than the claims that are released by this General
Release. I acknowledge that I may hereafter discover claims or facts in addition to or different than those which I now know or believe to exist with respect to the subject matter of the release set forth in paragraph 2 above and which, if known or
suspected at the time of entering into this General Release, may have materially affected this General Release and my decision to enter into it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding anything in this General Release to the contrary, this General Release shall not relinquish,
diminish, or in any way affect any rights or claims arising out of any breach by the Company or by any Released Party of the Agreement after the date hereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Whenever possible, each provision of this General Release shall be interpreted in, such manner as to be
effective and valid under applicable law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or
unenforceability shall not affect any other provision or any other jurisdiction, but this General Release shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained
herein. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I HAVE READ IT CAREFULLY; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO,
RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, AS AMENDED; TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963; THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT
OF 1974, AS AMENDED; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I VOLUNTARILY CONSENT TO EVERYTHING IN IT; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL
READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO OF MY OWN VOLITION; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I HAVE HAD AT LEAST <B>[21][45]</B>&nbsp;DAYS FROM THE DATE OF MY RECEIPT OF THIS RELEASE TO CONSIDER IT, AND
THE CHANGES MADE SINCE MY RECEIPT OF THIS RELEASE ARE NOT MATERIAL OR WERE MADE AT MY REQUEST AND WILL NOT RESTART THE REQUIRED<B>&nbsp;[21][45]</B>-DAY PERIOD; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I UNDERSTAND THAT I HAVE SEVEN (7)&nbsp;DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS
RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I HAVE SIGNED THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF ANY COUNSEL RETAINED TO
ADVISE ME WITH RESPECT TO IT; AND </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY
AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE COMPANY AND BY ME. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SIGNED: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">DATE: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>d833064dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SEPARATION AND CONSULTING AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Separation Agreement (this &#147;<U>Agreement</U>&#148;), dated May&nbsp;23, 2024, is effective as of the &#147;Effective Date&#148; (as
defined below), between Acadia Management Company, Inc. (the &#147;<U>Company</U>&#148;) and John Hollinsworth (&#147;<U>Employee</U>&#148; and with the Company, collectively, the &#147;<U>Parties</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>W I T N E S S E T H </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Employee is employed by the Company pursuant to an Employment Agreement, dated July&nbsp;31, 2019, between the Company and Employee
(the &#147;<U>Employment Agreement</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Employee has notified the Company that Employee intends to voluntarily resign
from his employment with the Company and position as Executive Vice President of Operations of the Company on June&nbsp;30, 2024, after which date, Employee shall provide Consulting Advisory Service (as defined below) to the Company as provided
under this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties wish to resolve all matters that Employee may have related to Employee&#146;s employment
and the termination of Employee&#146;s employment and consulting services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and the
releases, representations, covenants and obligations herein contained, the Parties, intending to be legally bound, hereby agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.<B>&#8195; <U>Cessation of Employment Relationship; Final Pay; COBRA</U>.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;Employee&#146;s employment with the Company shall cease effective as of June&nbsp;30, 2024, or such earlier date as determined by
the Company in its sole discretion (the &#147;<U>Employment Separation Date</U>&#148;), though until then Employee agrees the Company may reduce or eliminate some or all of Employee&#146;s duties, authorities and responsibilities in such manner and
at such time or times as it determines to be appropriate in its sole discretion without constituting a constructive termination or breach of any agreement with Employee. Employee and the Company agree that upon the Employment Separation Date,
Employee shall promptly resign, and shall be deemed to have resigned from all other officer, director and employment positions that Employee held at or through the Company, and any of its parents, subsidiaries or affiliates, and Employee agrees to
promptly execute such additional documentation as requested by the Company to effectuate the foregoing. The Employment Separation Date will be the termination date of Employee&#146;s employment for purposes of Employee&#146;s active participation in
and coverage under all benefit plans and programs sponsored by or through the Company or its affiliates, except as otherwise required by applicable law. For the avoidance of doubt, the parties acknowledge that Section&nbsp;4(f) of the Employment
Agreement regarding Employee&#146;s continuation of benefits following any termination of employment shall survive the execution of this Agreement and continue in full force and effect. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;Regardless of whether Employee executes this Agreement, the Company shall timely
pay to Employee, minus applicable withholdings and authorized or required deductions: (i)&nbsp;all earned, but unpaid, wages and accrued, but unused, vacation time earned in accordance with applicable law and Company policy through the Employment
Separation Date; (ii)&nbsp;any unpaid expenses or other reimbursements, due to Employee under the Company&#146;s policies, provided that Employee must submit for reimbursement any outstanding business-related expenses within ten (10)&nbsp;days
following the Employment Separation Date; and (iii)&nbsp;any amounts payable under the Company&#146;s applicable employee benefits plans and programs in accordance with their terms, including, without limitation, under the Company&#146;s
Nonqualified Deferred Compensation Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Employee will receive under separate cover information regarding Employee&#146;s
rights under the Consolidated Omnibus Budget Reconciliation Act and, if applicable, any state continuation coverage laws (collectively, &#147;<U>COBRA</U>&#148;). Employee acknowledges that Employee should review the COBRA notice and election forms
carefully to understand Employee&#146;s rights and obligations to make timely elections, provide timely notification and make timely premium payments. For the avoidance of doubt, the parties acknowledge that Section&nbsp;4(f) of the Employment
Agreement regarding Employee&#146;s continuation of benefits following any termination of employment shall survive the execution of this Agreement and continue in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;For the avoidance of doubt, all outstanding equity awards held by Employee shall be treated in accordance with the terms and
conditions of the Acadia Healthcare Company Inc., Incentive Compensation Plan and the applicable award agreement. Employee&#146;s separation from employment on the Employment Separation Date shall constitute a &#147;retirement&#148; for purposes of
all outstanding performance-vesting restricted stock unit equity awards held by Employee pursuant the terms of the applicable award agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&#8195;<B><U>Consulting Advisory Services</U></B>. During the period following the Employment Separation Date and ending on
December&nbsp;31, 2024 or such prior date as determined by the Company in its sole discretion upon notice to Employee (the &#147;<U>Consulting Advisory Period</U>&#148;), Employee shall make himself available to provide transition advisory services
as reasonably requested by the any of the Company&#146;s executive officers, the Company&#146;s Chief Executive Officer or the Board of Acadia Healthcare Company, Inc. (the &#147;<U>Consulting Advisory Services</U>&#148;). Employee will provide the
Consulting Advisory Services for no more than 30 hours per month. During the Consulting Advisory Period, in consideration of Employee&#146;s Consulting Advisory Services, continued compliance with the terms and conditions of this Agreement
(including, without limitation, Section&nbsp;5), the discharge of Employee&#146;s duties as Executive Vice President of Operations, and the timely execution of the ADEA Release in accordance with this Agreement, Employee shall be paid $10,000.00
(ten thousand dollars) per month, in accordance with the Company&#146;s standard payroll practices. With respect to services rendered during the Consulting Advisory Period, Employee&#146;s relationship to the Company will only be that of any
independent contractor and, as an independent contractor, Employee agrees to pay in a timely manner all social security and other payroll taxes relating to such compensation. The sole compensation Employee will receive for services during the
Consulting Advisory Period is set forth in this Section&nbsp;2 and Section&nbsp;3 below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&#8195;<B><U>Separation Payment</U></B>. Provided that Employee complies with this
Agreement and the &#147;ADEA Release&#148; (as defined below) becomes effective pursuant to its terms, Employee shall remain eligible to earn a prorated portion of Employee&#146;s annual bonus for the 2024 calendar year based on the number of
calendar days between January&nbsp;1, 2024 and the Employment Separation Date, such amount, if any, to be determined and paid in accordance with Section&nbsp;3(c) of the Employment Agreement at the same time such annual bonuses are paid to other
employees of the Company, less all applicable withholdings and authorized or required deductions. The payments under this Section&nbsp;3 are not earnings or wages under any Company 401(k) plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&#8195;<B><U>Confidentiality</U></B>. Subject to Section&nbsp;12 below, Employee agrees that the terms and conditions of this Agreement; the
circumstances of Employee&#146;s separation from the Company; all nonpublic, confidential, proprietary and trade secret information that Employee obtained or developed as result of Employee&#146;s employment with the Company; and any events relating
to the Company and/or the Company&#146;s employees that occurred during Employee&#146;s employment with the Company are strictly confidential, except that Employee may disclose the terms and conditions to Employee&#146;s attorneys, accountants, tax
consultants, state and federal tax authorities or as may otherwise be required by law (provided such parties are instructed to comply with this section). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&#8195;<B><U>Continuing Obligations</U></B>. Employee hereby reaffirms Employee&#146;s obligations under the Employment Agreement and agrees
to comply at all times with Employee&#146;s post-employment obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&#8195;<B><U>Release</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;In exchange for the consideration provided in this Agreement, Employee agrees that, to the maximum extent permitted by law,
Employee, on behalf of Employee, and Employee&#146;s heirs, beneficiaries, administrators, executors, trustees and assigns, shall, and hereby does, forever and irrevocably release and discharge the Company and each of its past, present and future
parents, subsidiaries, affiliates, portfolio companies and funds, and each of their past, present and future owners, officers, directors, employees, independent contractors, agents, affiliates, parents, subsidiaries, divisions, insurers, attorneys,
predecessors, employee benefit plans, purchasers, assigns, representatives, successors and successors in interest (collectively, the &#147;<U>Released Parties</U>&#148;) from any and all claims, suits, controversies, actions, causes of action,
cross-claims, counter claims, demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys&#146; fees, or liabilities of any nature whatsoever in law and in equity, both past
and present and whether known or unknown, suspected, unsuspected or claimed (collectively, &#147;<U>Claims</U>&#148;) against the Released Parties which Employee or any of Employee&#146;s heirs, executors, administrators or assigns, may have
(i)&nbsp;from the beginning of time through the date upon which Employee executes or <FONT STYLE="white-space:nowrap">re-executes</FONT> (as applicable) this Agreement; (ii)&nbsp;arising out of, or relating to, Employee&#146;s employment with or
services rendered to any Released Parties; (iii)&nbsp;arising out of, or relating to, any agreement and/or any awards, policies, plans, programs or practices of the Released Parties that may apply to Employee or in which Employee may participate,
including, but not limited to, any rights under bonus plans or programs of Released Parties and/or any other short-term or long-term equity-based or cash-based incentive plans or programs of the Released Parties; (iv)&nbsp;arising out of, or
relating to, Employee&#146;s termination of employment or services from any of the Released Parties; and/or (v)&nbsp;arising out of, or relating to, Employee&#146;s status as an employee, member, officer, director or consultant of any of the
Released Parties, including, but not limited to, any allegation, Claim or violation, arising under any federal, state or local civil or human rights law, or under any other local, state, or federal law, regulation or ordinance; or under any public
policy, contract or tort, or under common law; or arising under any policies, practices or procedures of the Company; or any Claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any Claim for costs,
fees, or other expenses, including attorneys&#146; fees incurred in these matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;Notwithstanding anything in this Agreement to the contrary, Employee&#146;s
release of Claims under the Age Discrimination in Employment Act, as amended (the &#147;<U>ADEA Release</U>&#148;) shall only become effective (i)&nbsp;with respect to Employee&#146;s release of Claims under the ADEA as of the Effective Date upon:
(x)&nbsp;Employee&#146;s initial separate signature set forth on the signature page of this Agreement reflecting Employee&#146;s assent to Employee&#146;s release of Claims under the ADEA as of the Effective Date and (y)&nbsp;Employee not revoking
such execution by the seventh (7th) calendar day following such execution; and (ii)&nbsp;with respect to Employee&#146;s release of Claims under the ADEA as of the date that Employee <FONT STYLE="white-space:nowrap">re-executes</FONT> this Agreement
upon: (x)&nbsp;Employee&#146;s second separate signature set forth on the signature page of this Agreement reflecting Employee&#146;s assent to Employee&#146;s release of Claims under the ADEA as of the date of such
<FONT STYLE="white-space:nowrap">re-execution</FONT> and (y)&nbsp;the occurrence of the ADEA Release Effective Date (as defined below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Employee represents and agrees that Employee has not, by himself/herself or on Employee&#146;s behalf, instituted, prosecuted,
filed, or processed any litigation, Claims or proceedings against the Company or any Released Parties, nor has Employee encouraged or assisted anyone to institute, prosecute, file, or process any litigation, Claims or proceedings against the Company
or any Released Parties. Nothing in this Section&nbsp;6 shall release or impair (i)&nbsp;any Claim or right that may arise after the date that Employee executes or <FONT STYLE="white-space:nowrap">re-executes</FONT> (as applicable) this Agreement;
(ii)&nbsp;any right to any earned and accrued base salary, vacation or benefits or incurred but unreimbursed business expense reimbursements or any severance or other benefits to which Employee is entitled under this Agreement (including, without
limitation, Section&nbsp;1 of this Agreement, which it is acknowledged Employee is entitled to receive as provided herein), (iii) any rights to vested ERISA benefits, as well as Employee&#146;s rights as an equity or security holder in the Company
or its affiliates; (iv)&nbsp;any Claim or right Employee may have pursuant to indemnification, advancement, defense, or reimbursement pursuant to any applicable D&amp;O policies, any similar insurance policies, applicable law or otherwise; and
(v)&nbsp;any Claim which by Federal, state or local law cannot be waived. Nothing in this Agreement is intended to prohibit or restrict Employee&#146;s right to file a charge with or participate in a charge by the Equal Employment Opportunity
Commission, or any other local, state, or federal administrative body or government agency; provided that Employee hereby waives the right to recover any monetary damages or other relief against any Released Parties; <U>provided</U>, <U>however</U>,
that nothing in this Agreement shall prohibit Employee from receiving any monetary award to which Employee becomes entitled pursuant to Section&nbsp;922 of the Dodd-Frank Wall Street Reform and Consumer Protection Act or awards under other
whistleblower laws that cannot be waived by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;Employee understands that Employee may later discover Claims or facts that may
be different than, or in addition to, those which Employee now knows or believes to exist with regards to the subject matter of this Agreement, and which, if known at the time of executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as
applicable) this Agreement, may have materially affected this Agreement or Employee&#146;s decision to enter into it. Employee hereby waives any right or Claim that might arise as a result of such different or additional Claims or facts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&#8195;Employee represents that Employee has made no assignment or transfer of any right
or Claim covered by this Section&nbsp;6 and that Employee further agrees that Employee is not aware of any such right or Claim covered by this Section&nbsp;6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&#8195;Employee understands, acknowledges, and agrees that any amounts paid to him in accordance with Section&nbsp;3 of this Agreement
exceed what Employee is otherwise entitled to receive upon separation from employment due to Employee&#146;s voluntary resignation, and that these benefits are being given as consideration in exchange for executing this Agreement, including the ADEA
Release contained in it. Employee understands that he will not receive any payments specified in Section&nbsp;3 unless Employee executes this Agreement including the ADEA Release contained in it, <FONT STYLE="white-space:nowrap">re-executes</FONT>
this Agreement for purposes of the ADEA Release (including upon expiration of the Consulting Advisory Period), and does not revoke the execution and <FONT STYLE="white-space:nowrap">re-execution</FONT> of the ADEA Release within the time period
permitted hereafter and thereafter. Employee acknowledges and agrees that, except as expressly set forth under this Agreement, Employee is not entitled to receive any additional compensation, bonus, equity compensation, payment in lieu of any paid
time off, equity awards, severance payments or other payments or benefits of any kind from the Company or its parents, subsidiaries or its affiliates or with respect to Employee&#146;s employment with the Company or any of its parents, subsidiaries
and affiliates, including, without limitation, any payments of any kind under the Employment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&#8195;In signing or <FONT
STYLE="white-space:nowrap">re-signing</FONT> (as applicable) the ADEA Release, Employee acknowledges and intends that it will be effective as a bar to each and every one of the released Claims hereinabove mentioned or implied. Employee expressly
consents that the ADEA Release will be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected released Claims (not withstanding any state or local statute that
expressly limits the effectiveness of a general release of unknown, unsuspected and unanticipated claims), if any, as well as those relating to any other released Claims hereinabove mentioned or implied. Employee acknowledges and agrees that this
waiver is an essential and material term of the ADEA Release and that without such waiver the Company would not have agreed to the terms of this Agreement. Employee further agrees that in the event Employee should seek to recover against the Company
in any released Claim brought by a governmental agency on Employee&#146;s behalf, the ADEA Release will serve as a complete defense to such released Claim to the maximum extent permitted by law. Employee further agrees that he is not aware of any
pending claim of the type described in Section&nbsp;6(a) above as of the execution and <FONT STYLE="white-space:nowrap">re-execution</FONT> (as applicable) of the ADEA Release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&#8195;<B><U>No Cooperation with <FONT STYLE="white-space:nowrap">Non-Governmental</FONT> Third Parties</U></B>. Employee agrees that, to
the maximum extent permitted by law, Employee will not encourage or voluntarily assist or aid in any way any <FONT STYLE="white-space:nowrap">non-governmental</FONT> attorneys or their clients or individuals acting on their own behalf in making or
filing any lawsuits, complaints, or other proceedings against the Company or any other Released Parties, and represents that Employee has not previously engaged in any such conduct. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&#8195;<B><U>Company Property</U></B>. Employee acknowledges and agrees that, other than
as expressly approved by the Company and necessary for the provision of the Consulting Advisory Services, Employee has returned, or will return within two (2)&nbsp;days after the Employment Separation Date, all Company property and <FONT
STYLE="white-space:nowrap">non-public,</FONT> confidential, proprietary and/or trade secret information in Employee&#146;s custody, possession or control, in any form whatsoever, including without limitation, equipment, telephones, smart phones,
work-related passwords; PDAs, laptops, credit cards, keys, access cards, identification cards, security devices, network access devices, pagers, confidential or proprietary information, documents, manuals, reports, books, compilations, work product,
<FONT STYLE="white-space:nowrap">e-mail</FONT> messages, recordings, tapes, removable storage devices, hard drives, computers and computer discs, files and data (collectively, &#147;<U>Company Property</U>&#148;), which Employee prepared or obtained
during the course of Employee&#146;s employment with the Company. If Employee discovers any property of the Company or <FONT STYLE="white-space:nowrap">non-public,</FONT> confidential, proprietary and/or trade secret information in Employee&#146;s
possession after the Effective Date, Employee shall promptly return such property to the Company or, at the instruction of the Company, destroy such property or information. Notwithstanding the foregoing, Employee further acknowledges and agrees
that Employee will return within two (2)&nbsp;days after the expiration of the Consulting Advisory Period any Company Property obtained during the Consulting Advisory Period or retained for use during the Consulting Advisory Period with express
approval by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&#8195;<B><U>No Admission of Liability; No Prevailing Party</U></B>. The Parties agree that this Agreement is
not to be construed as an admission of any wrongdoing or liability on the part of the Parties under any statute or otherwise, but that on the contrary, any such wrongdoing or liability is expressly denied by the Parties. The Parties agree that
neither this Agreement nor the negotiations in pursuance thereof shall be construed or interpreted to render the Parties a prevailing party for any reason, including but not limited to an award of attorney&#146;s fees, expenses or costs under any
statute or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&#8195;<B><U>Voluntary Execution</U></B>. Employee acknowledges, certifies and agrees that: (a)&nbsp;Employee
has carefully read this Agreement and fully understands all of its terms; (b)&nbsp;Employee had a reasonable amount of time to consider Employee&#146;s decision to execute or <FONT STYLE="white-space:nowrap">re-execute</FONT> (as applicable) this
Agreement; (c)&nbsp;in executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement Employee does not rely and has not relied upon any representation or statement made by any of the Company&#146;s agents,
representatives, or attorneys with regard to the subject matter, basis, or effect of the Agreement; and (d)&nbsp;that Employee enters into this Agreement voluntarily, of Employee&#146;s own free will, without any duress and with knowledge of its
meaning and effect in exchange for good and valuable consideration to which Employee would not be entitled in the absence of executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement and not revoking the ADEA
Release. Employee acknowledges that the Company has advised Employee to consult with an attorney prior to executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement and that Employee has had an opportunity to
consult with Employee&#146;s counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&#8195;<B><U>Review Period</U></B>. Employee has been given
<FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days from the date of Employee&#146;s receipt of this Agreement to consider the terms of this Agreement, although Employee may sign it at any time sooner; provided, that Employee may not <FONT
STYLE="white-space:nowrap">re-execute</FONT> the ADEA Release until the expiration of the Consulting Advisory Period. The Parties agree that any revisions or modifications to this Agreement, whether material or immaterial, will not and did not
restart this time period. The first date upon which Employee and the Company have signed this Agreement and the Company has received Employee&#146;s signature, shall be the &#147;<U>Effective Date</U>&#148;. Employee has seven (7)&nbsp;calendar days
after the date on which Employee initially executes this Agreement for purposes of the ADEA Release to revoke Employee&#146;s consent to the ADEA Release. If </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Employee does not sign this Agreement for purposes of the ADEA Release or if Employee revokes Employee&#146;s first execution of this Agreement for purposes of the ADEA Release, the ADEA Release
shall be null and void and the &#147;ADEA Release Effective Date&#148; (as defined below) shall not occur. Provided that Employee does not revoke Employee&#146;s first execution of this Agreement for purposes of the ADEA Release within such seven
(7)&nbsp;day revocation period, this ADEA Release will become effective on the eighth (8<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) calendar day after the date on which Employee signs this Agreement for purposes of the ADEA Release.
Employee&#146;s <FONT STYLE="white-space:nowrap">re-execution</FONT> of the ADEA Release advances the ADEA Release to the date of such <FONT STYLE="white-space:nowrap">re-execution.</FONT> After such
<FONT STYLE="white-space:nowrap">re-execution,</FONT> Employee has seven (7)&nbsp;calendar days to revoke Employee&#146;s consent to the advancement of the ADEA Release to the date of such <FONT STYLE="white-space:nowrap">re-execution.</FONT>
Provided that Employee does not revoke Employee&#146;s <FONT STYLE="white-space:nowrap">re-execution</FONT> of the ADEA Release within such seven (7)&nbsp;day revocation period, the ADEA Release will advance to the date of such <FONT
STYLE="white-space:nowrap">re-execution</FONT> effective on the eighth (8<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) calendar day after the date on which Employee <FONT STYLE="white-space:nowrap">re-executes</FONT> the ADEA Release (the
&#147;<U>ADEA Release Effective Date</U>&#148;). Employee must also <FONT STYLE="white-space:nowrap">re-execute</FONT> the ADEA release on, or within 21 days after, the expiration of the Consulting Advisory Period to remain eligible to receive the
benefits hereunder and must not revoke Employee&#146;s <FONT STYLE="white-space:nowrap">re-execution</FONT> of such ADEA Release within 7 days thereafter. If Employee does not <FONT STYLE="white-space:nowrap">re-execute</FONT> the ADEA Release or if
Employee revokes Employee&#146;s <FONT STYLE="white-space:nowrap">re-execution</FONT> of the ADEA Release, the Company&#146;s obligations under Section&nbsp;3 of this Agreement shall be null and void; however, the ADEA Release will remain in full
force and effect through the Effective Date. For purposes of the foregoing, any revocation must be in writing and must be emailed to Chris Hunter at Chris.Hunter@acadiahealthcare.com, and notice of such revocation must be received within the
applicable seven (7)&nbsp;calendar days referenced above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&#8195;<B><U>Permitted Disclosures</U></B>. Nothing in this Agreement or any
other agreement between the Parties or any other policies of the Company or its affiliates shall prohibit or restrict Employee or Employee&#146;s attorneys from: (a)&nbsp;making any disclosure of relevant and necessary information or documents in
any action, investigation, or proceeding relating to this Agreement, or as required by law or legal process, including with respect to possible violations of law; (b)&nbsp;participating, cooperating, or testifying in any action, investigation, or
proceeding with, or providing information to, any governmental agency or legislative body, any self-regulatory organization, and/or pursuant to the Sarbanes-Oxley Act; or (c)&nbsp;accepting any U.S. Securities and Exchange Commission awards or
awards under other whistleblower laws that cannot be waived by law. In addition, nothing in this Agreement or any other agreement between the Parties or any other policies of the Company or its affiliates prohibits or restricts Employee from
initiating communications with, or responding to any inquiry from, any regulatory or supervisory authority regarding any good faith concerns about possible violations of law or regulation. Pursuant to 18 U.S.C. &#167; 1833(b), Employee will not be
held criminally or civilly liable under any Federal or state trade secret law for the disclosure of a trade secret of the Company or its affiliates that (i)&nbsp;is made (x)&nbsp;in confidence to a Federal, state, or local government official,
either directly or indirectly, or to Employee&#146;s attorney and (y)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law; or (ii)&nbsp;is made in a complaint or other document that is filed under seal in a lawsuit
or other proceeding. If Employee files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Employee may disclose the trade secret to Employee&#146;s attorney and use the trade secret information in the court
proceeding, if Employee files any document containing the trade secret under seal, and does not disclose the trade secret, except pursuant to court order. Nothing in this Agreement or any other agreement between the Parties or any other policies of
the Company or its affiliates is intended to conflict with 18 U.S.C. &#167; 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such section. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&#8195;<B><U>Successors and Assigns; Third-Party Beneficiaries</U></B>. The Parties agree
that this Agreement shall inure to the benefit of the personal representatives, heirs, executors, and administrators of Employee. This Agreement may not be assigned by Employee. The Company may freely assign all rights and obligations of this
Agreement to any affiliate or successor (including to a purchaser of assets). The Released Parties are expressly intended to be third-party beneficiaries of this Agreement and it may be enforced by each of them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&#8195;<B><U>No Oral Modifications</U></B>. This Agreement shall not be modified except in writing signed by Employee and an authorized
representative of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&#8195;<B><U>Severability</U></B>. If any terms of the above provisions of this Agreement are found
null, void or inoperative, for any reason, the remaining provisions will remain in full force and effect. The language of all parts of this Agreement shall in all cases be construed as a whole, according to its fair meaning, and not strictly for or
against either of the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&#8195;<B><U>Counterparts</U></B>. This Agreement may be executed in counterparts, each of which will
be deemed an original but all of which together will constitute one and the same instrument. An originally executed version of this Agreement that is scanned as an image file (e.g., Adobe PDF, TIF, etc.) and then delivered by one Party to the other
Party via electronic mail as evidence of signature, shall, for all purposes hereof, be deemed an original signature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&#8195;<B><U>Governing Law; Jurisdiction; Waiver of Jury Trial</U></B>. The Parties agree that this Agreement and the rights and
obligations hereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware regardless of any principles of conflicts of laws or choice of laws of any jurisdiction. The Parties agree that any action between
Employee and the Company shall be resolved exclusively in a federal or state court in Tennessee, and the Company and Employee hereby consent to such jurisdiction and waive any objection to the jurisdiction of any such court. As a specifically
bargained for inducement for each of the Parties to enter into this Agreement, Employee and the Company (after having the opportunity to consult with counsel) hereby waive trial by jury as to any and all litigation arising out of and/or relating to
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&#8195;<B><U>Entire Agreement</U></B>. This Agreement and the Employment Agreement constitute the complete and entire
agreement and understanding of the Parties, and supersede in their entirety any and all prior understandings, negotiations, commitments, obligations and/or agreements, whether written or oral, between the Parties. The Parties represent that, in
executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement, each Party has not relied upon any representation or statement made by the other Party, other than those set forth in this Agreement, with regard to
the subject matter, basis or effect of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have duly executed or
<FONT STYLE="white-space:nowrap">re-executed,</FONT> as applicable, this Agreement as of the below-indicated date(s). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="50%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYEE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John Hollinsworth</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">May&nbsp;23, 2024</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John Hollinsworth</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="50%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>ACADIA MANAGEMENT COMPANY, LLC</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Hunter</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">May&nbsp;23, 2024</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(Signature)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: Christopher Hunter</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: President</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AGREED AND ACKNOWLEDGED <U> </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>WITH RESPECT TO FIRST EXECUTION OF ADEA RELEASE</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="50%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYEE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/John Hollinsworth</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">May&nbsp;23, 2024</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John Hollinsworth</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>*NOT TO BE SIGNED PRIOR TO THE EXPIRATION OF THE CONSULTING ADVISORY PERIOD* </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AGREED AND ACKNOWLEDGED <U> </U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>WITH RESPECT TO <FONT
STYLE="white-space:nowrap">RE-EXECUTION</FONT> OF ADEA RELEASE</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="50%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYEE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John Hollinsworth</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>achc-20240523.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/24/2024 2:28:54 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:achc="http://www.acadiahealthcare.com/20240523"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.acadiahealthcare.com/20240523"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achc-20240523_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achc-20240523_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>achc-20240523_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/24/2024 2:28:54 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>achc-20240523_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/24/2024 2:28:54 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="achc-20240523.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140104405586896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 23, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001520697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 23,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Acadia Healthcare Company, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-2492228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6100 Tower Circle<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Franklin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">861-6000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACHC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M9(^#B]@1%D6*"EXOR/?>I4=)"G7Q&X]R%+,V?8:[]$)#V07A-M_%2]4<;+C
M9/HPQ4AJBV>X'5<3=O<>;'BR%B<+R1:AY\G\=O(KQE1[.SO+V^]BH==VEGX!
M!;,Y5*:-;+C@R?ARC][+[3>.)VZ?F)%(K$#(N[R",>ORLT'9,"HM7M67RL"+
M?W&X$1QBW]X UU=*F4/#OOU7'V_&_P)02P,$%     @ &DBX6)^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ &DBX6 =!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    "  :2+A8C/EH.N\    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    "  :2+A8F5R<(Q &  "<)P  $P
M        @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !I(
MN%@Y+;[?>P0  ,@1   8              " @0X(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    "  :2+A8GZ ;\+$"  #B#   #0
M        @ &_#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( !I(N%B7BKL<
MP    !,"   +              "  9L/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( !I(N%@<.&7J/P$  #P"   /              "  800  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    "  :2+A8)!Z;HJT   #X 0  &@
M    @ 'P$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M"  :2+A899!YDAD!  #/ P  $P              @ '5$@  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"   ?%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d833064d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>achc-20240523.xsd</File>
    <File>achc-20240523_lab.xml</File>
    <File>achc-20240523_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d833064d8k.htm">d833064d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d833064d8k.htm": {
   "nsprefix": "achc",
   "nsuri": "http://www.acadiahealthcare.com/20240523",
   "dts": {
    "schema": {
     "local": [
      "achc-20240523.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "achc-20240523_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "achc-20240523_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d833064d8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-05-23_to_2024-05-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d833064d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-05-23_to_2024-05-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d833064d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.acadiahealthcare.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-24-146576-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-146576-xbrl.zip
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MQ&%#WW%]E&%8!?<^B$M9K03RC(+<!M %%0UHNZEY[% Y8:V/]TPM%?-0<)7
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ML W+PZ@8/IFNAR9#6"Z'XB/6=!Q4.5C:32N>9ZM$JXXWH?BG.4V?ZX8'E-(
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M JGT^AB,1V/Z7Z15<J\$FDB>@^I:1+-?7F5Y=L\P9-"$\/%7:#P2U< 8:P>
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M13)-YU.35"VU6V#Y8T6'I+9G531!OW\Y9\GCI\_",[_J7S@7RBRA1:Q(/\E
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MU[^54R74)+^"'$,_=&%N3"#$\479*LWT35MQ7B\UQ\N^;HHW5G^^B=$04IH
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M9CPAR\J#;;<<[F';AE-A=Q:C50B+0ETA$]F232KB.'F@)1Z'K] ?+:ML E&
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M1G$BN&Z7J87(QDV<)!&G2$YR\7<@$C_C98U1,BCDM%&!X>@T _Y JL24BES
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M9YX+M&?+O2,N)< F)37G%NP<;Y:V$J'/V"P3.-%X8>&1[@?>BNG_+/0DOF,
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M=P.DVW?PQ=,^R/KCT^!##WY)K\.<Z=W_?M\[X^ORH0]J#[X !A%PY@%-%Q\
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M&_P/M\U8UQ)H36,@5+%O=_8O_?9#07OX!E3HXX./\,NW@W>'K_X_4$L#!!0
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M)#(<27 3&Q&2'2V4>=-08=WD0.OC*K&65^"@;?7D\%3&,)8EODS#05%J@W&
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MV&_+5=7-@A$ZEAO5&TN[.%H(<S6"VX*5Z_?,&?26V@[AQ]/XYH9/Y'^:'-+
M^N,+[5'0CB M,"O3,$VW!18M>XC?WA*:B[;=)>QT([//A;#XK9LA<J*$%!7:
M$0C,]_'6$WA8:+NE297(LT5\F4EQ+08/J!;E]X,O+D(O.GUD8.(C-7'*L#T
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M>HU4GK#JIQ2G8EVZI';+<'+GV'+FH2R32$F$$H6C]%5V,*I0=NY1/ ;RX(C
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MEM!G)5\&-\R._)RJ6L<ZBXZA#4:4IMGG&6*K!<?[.;O,F$^YL77E,-K"&"^
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M$_%^2%9.4<]6D5!PG3?FH_C",98[*XV0\]HH%*L?D0=4 L#2K*Y)G!^Q)R$
MQAHNVYK.G(3.'-J44:E@LP2Y]^D6@IR*U:","I8FDU?>UW"_L!9:5 J@:4S
MJ(&<"'LV3*$-05@N2V-%V7\GQ_-+-3YL^A]"-A@5N=?_ Q1_.*@+*K!G($?8
MQ/0BB3V5%(NC%:8Q@I>)P2P (\RQ+G=HB!0%P"]@L$\P_ #]@<.8& V6B-BT
MSY&NR$\B]:"R"+/!0$5=I$TN4V0B>893XGW.%^C^4G5"N$0Q;$=D"KG%' H^
M0B#!PQ2H>0.5[4)203PN+_0;:*P(_9>\G-E$PO)EY?"B"?RCF";T@E 28FJV
M#CMAHL K?MQ8G1=KC.!VL3H<ZP4\,[ZRC*^DNQ"R1:8G\'#@MU/,E3#41IJ
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MN_ GQ<W!,),4"2$RX958!54PZU)N/L4,-!<&"7D\F):IT*/)JIR!P'67//<
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M4>_73^__/U!+ 0(4 Q0    ( !I(N%B%1V?,00,  &0+   1
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M-C1D97@Q,#$N:'1M4$L! A0#%     @ &DBX6*F6>-(6*0  /[8  !$
M         ( !JXH  &0X,S,P-C1D97@Q,#(N:'1M4$L! A0#%     @ &DBX
M6(2T[,99-0  J50! !               ( !\+,  &0X,S,P-C1D97@S,2YH
8=&U02P4&      < !P"] 0  =^D

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d833064d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="achc-20240523.xsd" xlink:type="simple"/>
    <context id="duration_2024-05-23_to_2024-05-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
        </entity>
        <period>
            <startDate>2024-05-23</startDate>
            <endDate>2024-05-23</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-500">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-05-23_to_2024-05-23"
      id="Hidden_dei_EntityCentralIndexKey">0001520697</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2024-05-23_to_2024-05-23"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2024-05-23_to_2024-05-23">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-512">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-513">2024-05-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-514">Acadia Healthcare Company, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-515">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-516">001-35331</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-517">45-2492228</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-518">6100 Tower Circle</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-519">Suite 1000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-520">Franklin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-521">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-522">37067</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-523">(615)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-524">861-6000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-525">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-526">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-527">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-528">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-529">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-530">ACHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-531">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-532">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
